{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:51:20Z","timestamp":1789001480564,"version":"build-2803163510"},"reference-count":503,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Emerging viral zoonotic diseases are one of the major obstacles to secure the \u201cOne Health\u201d concept under the current scenario. Current prophylactic, diagnostic and therapeutic approaches often associated with certain limitations and thus proved to be insufficient for customizing rapid and efficient combating strategy against the highly transmissible pathogenic infectious agents leading to the disastrous socio-economic outcome. Moreover, most of the viral zoonoses originate from the wildlife and poor knowledge about the global virome database renders it difficult to predict future outbreaks. Thus, alternative management strategy in terms of improved prophylactic vaccines and their delivery systems; rapid and efficient diagnostics and effective targeted therapeutics are the need of the hour.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Structured literature search has been performed with specific keywords in bibliographic databases for the accumulation of information regarding current nanomedicine interventions along with standard books for basic virology inputs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Multi-arrayed applications of nanomedicine have proved to be an effective alternative in all the aspects regarding the prevention, diagnosis, and control of zoonotic viral diseases. The current review is focused to outline the applications of nanomaterials as anti-viral vaccines or vaccine\/drug delivery systems, diagnostics and directly acting therapeutic agents in combating the important zoonotic viral diseases in the recent scenario along with their potential benefits, challenges and prospects to design successful control strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>This review provides significant introspection towards the multi-arrayed applications of nanomedicine to combat several important zoonotic viral diseases.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026620666200325114400","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T14:35:51Z","timestamp":1585146951000},"page":"915-962","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["An Insight into Nanomedicinal Approaches to Combat Viral Zoonoses"],"prefix":"10.2174","volume":"20","author":[{"given":"Prasad","family":"Minakshi","sequence":"first","affiliation":[{"name":"Department of Animal Biotechnology, LLR University of Veterinary and Animal Sciences, Hisar-125001, Haryana, 125004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayukh","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology and Biochemistry, RGSC, Banaras Hindu University, Mirzapur (UP) - 231001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology and Biochemistry, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar-125001, Haryana, 125004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basanti","family":"Brar","sequence":"additional","affiliation":[{"name":"Department of Animal Biotechnology, LLR University of Veterinary and Animal Sciences, Hisar-125001, Haryana, 125004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra P.","family":"Lambe","sequence":"additional","affiliation":[{"name":"Department of Animal Biotechnology, LLR University of Veterinary and Animal Sciences, Hisar-125001, Haryana, 125004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Veterinary Microbiology, Immunology Section, LUVAS, Hisar-125004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushlesh","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology and Biochemistry, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balvinder","family":"Kumar","sequence":"additional","affiliation":[{"name":"ICAR-NRCE, Hisar, Haryana, 125001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, LLR University of Veterinary and Animal Sciences, Hisar, Haryana, 125004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashpal S.","family":"Malik","sequence":"additional","affiliation":[{"name":"Division of Standardisation, Indian Veterinary Research Institute Izatnagar - Bareilly (UP) - 243122, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaya","family":"Prasad","sequence":"additional","affiliation":[{"name":"Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, UP, 250110, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.aap7463","volume":"359","author":"Carroll D.","year":"2018","unstructured":"Carroll D.; Daszak P.; Wolfe N.D.; Gao G.F.; Morel C.M.; Morzaria S.; Pablos-M\u00e9ndez A.; Tomori O.; Mazet J.A.K.; The Global Virome Project. Science 2018,359(6378),872-874","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature22975","volume":"546","author":"Olival K.J.","year":"2017","unstructured":"Olival K.J.; Hosseini P.R.; Zambrana-Torrelio C.; Ross N.; Bogich T.L.; Daszak P.; Host and viral traits predict zoonotic spillover from mammals. Nature 2017,546(7660),646-650","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2471\/BLT.17.205005","volume":"96","author":"Carroll D.","year":"2018","unstructured":"Carroll D.; Watson B.; Togami E.; Daszak P.; Mazet J.A.; Chrisman C.J.; Rubin E.M.; Wolfe N.; Morel C.M.; Gao G.F.; Burci G.L.; Fukuda K.; Auewarakul P.; Tomori O.; Building a global atlas of zoonotic viruses. Bull World Health Organ 2018,96(4),292-294","journal-title":"Bull World Health Organ"},{"key":"ref=4","author":"Roser M.","year":"2018","unstructured":"Roser M.; Life Expectancy. OurWorldInDataorg 2018","journal-title":"OurWorldInDataorg"},{"key":"ref=5","year":"2019","unstructured":"World Health Organization. Disease outbreaks by year WHO 2019","journal-title":"WHO"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"14830","DOI":"10.1038\/srep14830","volume":"5","author":"Kreuder Johnson C.","year":"2015","unstructured":"Kreuder Johnson C.; Hitchens P.L.; Smiley Evans T.; Goldstein T.; Thomas K.; Clements A.; Joly D.O.; Wolfe N.D.; Daszak P.; Karesh W.B.; Mazet J.K.; Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci Rep 2015,5,14830","journal-title":"Sci Rep"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41467-017-00923-8","volume":"8","author":"Allen T.","year":"2017","unstructured":"Allen T.; Murray K.A.; Zambrana-Torrelio C.; Morse S.S.; Rondinini C.; Di Marco M.; Breit N.; Olival K.J.; Daszak P.; Global hotspots and correlates of emerging zoonotic diseases. Nat Commun 2017,8(1),1124","journal-title":"Nat Commun"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/nature06536","volume":"451","author":"Jones K.E.","year":"2008","unstructured":"Jones K.E.; Patel N.G.; Levy M.A.; Storeygard A.; Balk D.; Gittleman J.L.; Daszak P.; Global trends in emerging infectious diseases. Nature 2008,451(7181),990-993","journal-title":"Nature"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.nurpra.2017.12.025","volume":"14","author":"O\u2019Neil J.","year":"2018","unstructured":"O\u2019Neil J.; Zoonotic Infections From Common Household Pets. J Nurse Pract 2018,14(5),363-370","journal-title":"J Nurse Pract"},{"key":"ref=10","first-page":"48","volume":"318","author":"Christiansen J.","year":"2018","unstructured":"Christiansen J.; Global Infections by the Numbers. Sci Am 2018,318,48","journal-title":"Sci Am"},{"key":"ref=11","year":"2017","unstructured":"Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System CDC 2017","journal-title":"CDC"},{"key":"ref=12","unstructured":"CDC. Sexually transmitted disease Surveillance. Available from: (Accessed 2017)."},{"key":"ref=13","year":"2018","unstructured":"World Health Organization. Global Health Estimates (GHE)2018"},{"key":"ref=14","year":"2018","unstructured":"Disease burden and mortality estimates, WHO World Health Organization.2018"},{"key":"ref=15","year":"2018","unstructured":"Deaths by cause, age, sex, by country and by region, 2000-2016. Global Health Estimates2018"},{"key":"ref=16","year":"2018","unstructured":"World Health Organization. Influenza (Seasonal) WHO Available from:2018","journal-title":"WHO"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2471\/BLT.12.101873","volume":"90","author":"Morris S.K.","year":"2012","unstructured":"Morris S.K.; Awasthi S.; Khera A.; Bassani D.G.; Kang G.; Parashar U.D.; Kumar R.; Shet A.; Glass R.I.; Jha P.; Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths. Bull World Health Organ 2012,90(10),720-727","journal-title":"Bull World Health Organ"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","volume":"378","author":"Nair H.","year":"2011","unstructured":"Nair H.; Brooks W.A.; Katz M.; Roca A.; Berkley J.A.; Madhi S.A.; Simmerman J.M.; Gordon A.; Sato M.; Howie S.; Krishnan A.; Ope M.; Lindblade K.A.; Carosone-Link P.; Lucero M.; Ochieng W.; Kamimoto L.; Dueger E.; Bhat N.; Vong S.; Theodoratou E.; Chittaganpitch M.; Chimah O.; Balmaseda A.; Buchy P.; Harris E.; Evans V.; Katayose M.; Gaur B.; O\u2019Callaghan-Gordo C.; Goswami D.; Arvelo W.; Venter M.; Briese T.; Tokarz R.; Widdowson M.A.; Mounts A.W.; Breiman R.F.; Feikin D.R.; Klugman K.P.; Olsen S.J.; Gessner B.D.; Wright P.F.; Rudan I.; Broor S.; Sim\u00f5es E.A.; Campbell H.; Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011,378(9807),1917-1930","journal-title":"Lancet"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1086\/605496","volume":"49","author":"Staples J.E.","year":"2009","unstructured":"Staples J.E.; Breiman R.F.; Powers A.M.; Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009,49(6),942-948","journal-title":"Clin Infect Dis"},{"key":"ref=20","year":"2010","unstructured":"Asia Pacific Strategy for Emerging Diseases World Health Organization2010"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5491\/SHAW.2012.3.1.77","volume":"3","author":"Rabozzi G.","year":"2012","unstructured":"Rabozzi G.; Bonizzi L.; Crespi E.; Somaruga C.; Sokooti M.; Tabibi R.; Vellere F.; Brambilla G.; Colosio C.; Emerging zoonoses: the \u201cone health approach\u201d. Saf Health Work 2012,3(1),77-83","journal-title":"Saf Health Work"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/embo-reports\/kve122","volume":"2","author":"Sobrino F.","year":"2001","unstructured":"Sobrino F.; Domingo E.; Foot-and-mouth disease in Europe. FMD is economically the most important disease of farm animals. Its re-emergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade. EMBO Rep 2001,2(6),459-461","journal-title":"EMBO Rep"},{"key":"ref=23","unstructured":"RTHK. HK plans pig cull after second swine fever case Available from: (Accessed in 2018)."},{"key":"ref=24","unstructured":"Phys.org. Japan culling 122,000 more birds for avian flu. Available from: (Accessed in 2016)."},{"key":"ref=25","author":"McLeod A.","year":"2005","unstructured":"McLeod A.; Morgan N.; Prakash A.; Hinrichs J.; Economic and Social Impacts of Avian Influenza 2005","journal-title":"Economic and Social Impacts of Avian Influenza"},{"key":"ref=26","year":"2010","unstructured":"World Bank2010"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jviromet.2008.01.004","volume":"149","author":"Litzba N.","year":"2008","unstructured":"Litzba N.; Schuffenecker I.; Zeller H.; Drosten C.; Emmerich P.; Charrel R.; Kreher P.; Niedrig M.; Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 2008,149(1),175-179","journal-title":"J Virol Methods"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1086\/529444","volume":"46","author":"Lakshmi V.","year":"2008","unstructured":"Lakshmi V.; Neeraja M.; Subbalaxmi M.V.; Parida M.M.; Dash P.K.; Santhosh S.R.; Rao P.V.; Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin Infect Dis 2008,46(9),1436-1442","journal-title":"Clin Infect Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.coviro.2013.06.007","volume":"3","author":"Ahmed R.","year":"2013","unstructured":"Ahmed R.; Burton D.R.; Viral vaccines: past successes and future challenges. Curr Opin Virol 2013,3(3),307-308","journal-title":"Curr Opin Virol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","volume":"11","author":"Pelaz B.","year":"2017","unstructured":"Pelaz B.; Alexiou C.; Alvarez-Puebla R.A.; Alves F.; Andrews A.M.; Ashraf S.; Balogh L.P.; Ballerini L.; Bestetti A.; Brendel C.; Bosi S.; Carril M.; Chan W.C.; Chen C.; Chen X.; Chen X.; Cheng Z.; Cui D.; Du J.; Dullin C.; Escudero A.; Feliu N.; Gao M.; George M.; Gogotsi Y.; Gr\u00fcnweller A.; Gu Z.; Halas N.J.; Hampp N.; Hartmann R.K.; Hersam M.C.; Hunziker P.; Jian J.; Jiang X.; Jungebluth P.; Kadhiresan P.; Kataoka K.; Khademhosseini A.; Kope\u010dek J.; Kotov N.A.; Krug H.F.; Lee D.S.; Lehr C.M.; Leong K.W.; Liang X.J.; Ling Lim M.; Liz-Marz\u00e1n L.M.; Ma X.; Macchiarini P.; Meng H.; M\u00f6hwald H.; Mulvaney P.; Nel A.E.; Nie S.; Nordlander P.; Okano T.; Oliveira J.; Park T.H.; Penner R.M.; Prato M.; Puntes V.; Rotello V.M.; Samarakoon A.; Schaak R.E.; Shen Y.; Sj\u00f6qvist S.; Skirtach A.G.; Soliman M.G.; Stevens M.M.; Sung H.W.; Tang B.Z.; Tietze R.; Udugama B.N.; VanEpps J.S.; Weil T.; Weiss P.S.; Willner I.; Wu Y.; Yang L.; Yue Z.; Zhang Q.; Zhang Q.; Zhang X.E.; Zhao Y.; Zhou X.; Parak W.J.; Diverse Applications of Nanomedicine. ACS Nano 2017,11(3),2313-2381","journal-title":"ACS Nano"},{"key":"ref=31","author":"Maclachlan N.","year":"2016","unstructured":"Maclachlan N.; Dubovi E.J.; Fenner\u2019s Veterinary Virology 2016","journal-title":"Fenner\u2019s Veterinary Virology"},{"key":"ref=32","author":"Knipe D.M.","year":"2013","unstructured":"Knipe D.M.; Howley P.M.; Fields Virology 2013","journal-title":"Fields Virology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tmaid.2019.04.011","volume":"30","author":"Kumar B.","year":"2019","unstructured":"Kumar B.; Manuja A.; Tripathi B.N.; Why trans-boundary and one health preparedness for Rift Valley fever is required. Travel Med Infect Dis 2019,30,139-140","journal-title":"Travel Med Infect Dis"},{"key":"ref=34","year":"2018","unstructured":"World Health Organization. Rift valley fever, Available from:2018"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198570028.001.0001","author":"Palmer S.R.","year":"2011","unstructured":"Palmer S.R.; Oxford textbook of zoonoses: biology, clinical practice, and public health control 2011","journal-title":"Oxford textbook of zoonoses: biology, clinical practice, and public health control"},{"key":"ref=36","year":"2016","unstructured":"CDC. Rift Valley Fever(RVF) Available from: (Accessed on 23 November, 2018).2016"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jinf.2011.07.011","volume":"63","author":"Kocak Tufan Z.","year":"2011","unstructured":"Kocak Tufan Z.; Weidmann M.; Bulut C.; Kinikli S.; Hufert F.T.; Dobler G.; Demiroz A.P.; Clinical and laboratory findings of a sandfly fever Turkey Virus outbreak in Ankara. J Infect 2011,63(5),375-381","journal-title":"J Infect"},{"key":"ref=38","author":"Karabatsos N.","year":"1985","unstructured":"Karabatsos N.; International catalogue of arboviruses: including certain other viruses of vertebrates. Published for the Subcommittee on Information Exchange of the American Committee on Arthropod-borne Viruses by the American Society of Tropical Medicine and Hygiene 1985","journal-title":"Published for the Subcommittee on Information Exchange of the American Committee on Arthropod-borne Viruses by the American Society of Tropical Medicine and Hygiene"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1469-0691.2005.01330.x","volume":"12","author":"Papa A.","year":"2006","unstructured":"Papa A.; Konstantinou G.; Pavlidou V.; Antoniadis A.; Sandfly fever virus outbreak in Cyprus. Clin Microbiol Infect 2006,12(2),192-194","journal-title":"Clin Microbiol Infect"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3201\/eid1405.071487","volume":"14","author":"Izri A.","year":"2008","unstructured":"Izri A.; Temmam S.; Moureau G.; Hamrioui B.; de Lamballerie X.; Charrel R.N.; Sandfly fever Sicilian virus, Algeria. Emerg Infect Dis 2008,14(5),795-797","journal-title":"Emerg Infect Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jiph.2016.02.014","volume":"10","author":"Shiraly R.","year":"2017","unstructured":"Shiraly R.; Khosravi A.; Farahangiz S.; Seroprevalence of sandfly fever virus infection in military personnel on the western border of Iran. J Infect Public Health 2017,10(1),59-63","journal-title":"J Infect Public Health"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00001432-200310000-00003","volume":"16","author":"Dionisio D.","year":"2003","unstructured":"Dionisio D.; Esperti F.; Vivarelli A.; Valassina M.; Epidemiological, clinical and laboratory aspects of sandfly fever. Curr Opin Infect Dis 2003,16(5),383-388","journal-title":"Curr Opin Infect Dis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3201\/eid1105.041122","volume":"11","author":"Peyrefitte C.N.","year":"2005","unstructured":"Peyrefitte C.N.; Devetakov I.; Pastorino B.; Villeneuve L.; Bessaud M.; Stolidi P.; Depaquit J.; Segura L.; Gravier P.; Tock F.; Durand F.; Vagneur J.P.; Tolou H.J.; Grandadam M.; Toscana virus and acute meningitis, France. Emerg Infect Dis 2005,11(5),778-780","journal-title":"Emerg Infect Dis"},{"key":"ref=44","year":"2014","unstructured":"CDC. Crimean-Congo Hemorrhagic Fever (CCHF) Available from: (Accessed on 23rd November, 2018).2014"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/trstmh\/trv050","volume":"109","author":"Messina J.P.","year":"2015","unstructured":"Messina J.P.; Pigott D.M.; Golding N.; Duda K.A.; Brownstein J.S.; Weiss D.J.; Gibson H.; Robinson T.P.; Gilbert M.; William Wint G.R.; Nuttall P.A.; Gething P.W.; Myers M.F.; George D.B.; Hay S.I.; The global distribution of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg 2015,109(8),503-513","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3201\/eid2412.180175","volume":"24","author":"Voorhees M.A.","year":"2018","unstructured":"Voorhees M.A.; Padilla S.L.; Jamsransuren D.; Koehler J.W.; Delp K.L.; Adiyadorj D.; Baasandagwa U.; Jigjav B.; Olschner S.P.; Minogue T.D.; Schoepp R.J.; Crimean-congo hemorrhagic fever virus, Mongolia, 2013-2014. Emerg Infect Dis 2018,24(12),2202-2209","journal-title":"Emerg Infect Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3201\/eid2306.161950","volume":"23","author":"Yadav P.D.","year":"2017","unstructured":"Yadav P.D.; Thacker S.; Patil D.Y.; Jain R.; Mourya D.T.; Crimean-congo hemorrhagic fever in migrant worker returning from Oman to India, 2016. Emerg Infect Dis 2017,23(6),1005-1008","journal-title":"Emerg Infect Dis"},{"key":"ref=48","year":"2018","unstructured":"CDC. Understanding crimean-congo hemorrhagic fever in Kazakhstan Available from: (Accessed on 23rd November, 2018).2018"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","volume":"6","author":"Erg\u00f6n\u00fcl O.","year":"2006","unstructured":"Erg\u00f6n\u00fcl O.; Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006,6(4),203-214","journal-title":"Lancet Infect Dis"},{"key":"ref=50","year":"2013","unstructured":"World Health Organization. Crimean-Congo haemorrhagic fever Available from: (Accessed on 24th November, 2018).2013"},{"key":"ref=51","year":"2013","unstructured":"CDC. Crimean-congo hemorrhagic fever (CCHF) Available from: (Accessed on: 24th November, 2018).2013"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4049\/jimmunol.69.5.493","volume":"69","author":"Hammon W.M.","year":"1952","unstructured":"Hammon W.M.; Reeves W.C.; Sather G.; California encephalitis virus, a newly described agent. II. Isolations and attempts to identify and characterize the agent. J Immunol 1952,69(5),493-510","journal-title":"J Immunol"},{"key":"ref=53","first-page":"303","volume":"77","author":"Hammon W.M.","year":"1952","unstructured":"Hammon W.M.; Reeves W.C.; California encephalitis virus, a newly described agent. Calif Med 1952,77(5),303-309","journal-title":"Calif Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3201\/eid0703.017316","volume":"7","author":"Eldridge B.F.","year":"2001","unstructured":"Eldridge B.F.; Glaser C.; Pedrin R.E.; Chiles R.E.; The first reported case of California encephalitis in more than 50 years. Emerg Infect Dis 2001,7(3),451-452","journal-title":"Emerg Infect Dis"},{"key":"ref=55","year":"2019","unstructured":"CDC. La Crosse Encephalitis Available from: (Accessed on 24th November, 2018).2019"},{"key":"ref=56","year":"2016","unstructured":"Medscape. California encephalitis Available from: (Accessed on 24th November, 2018).2016"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"330","DOI":"10.18043\/ncm.77.5.330","volume":"77","author":"Byrd B.D.","year":"2016","unstructured":"Byrd B.D.; La Crosse Encephalitis: A Persistent Arboviral Threat in North Carolina. N C Med J 2016,77(5),330-333","journal-title":"N C Med J"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3201\/eid1204.051010","volume":"12","author":"Gould E.A.","year":"2006","unstructured":"Gould E.A.; Higgs S.; Buckley A.; Gritsun T.S.; Potential arbovirus emergence and implications for the United Kingdom. Emerg Infect Dis 2006,12(4),549-555","journal-title":"Emerg Infect Dis"},{"key":"ref=59","first-page":"81","volume":"4","author":"Bulychev V.P.","year":"1985","unstructured":"Bulychev V.P.; Alekseev A.N.; Kostiukov M.A.; Tukhtaev T.M.; Gordeeva Z.E.; [Isolation of Tahyna virus from mosquitoes collected in Dushanbe]. Med Parazitol (Mosk) 1985,4(4),81-83","journal-title":"Med Parazitol (Mosk)"},{"key":"ref=60","first-page":"682","volume":"6","author":"L\u2019vov D.K.","year":"1977","unstructured":"L\u2019vov D.K.; Kostiukov M.A.; Pak T.P.; Gordeeva Z.E.; Bun\u2019etbekov A.A.; Isolation of Tahyna virus (California antigenic group, family Bunyaviridae) from the blood of febrile patients in the Tadzhik SSR). Vopr Virusol [in Russian].1977,6(6),682-685","journal-title":"Vopr Virusol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3201\/eid1101.040444","volume":"11","author":"Hub\u00e1lek Z.","year":"2005","unstructured":"Hub\u00e1lek Z.; Zeman P.; Halouzka J.; Juricov\u00e1 Z.; Stovickov\u00e1 E.; B\u00e1lkov\u00e1 H.; Sikutov\u00e1 S.; Rudolf I.; Mosquitoborne viruses, Czech Republic, 2002. Emerg Infect Dis 2005,11(1),116-118","journal-title":"Emerg Infect Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1743-422X-8-135","volume":"8","author":"Bennett R.S.","year":"2011","unstructured":"Bennett R.S.; Gresko A.K.; Murphy B.R.; Whitehead S.S.; Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys. Virol J 2011,8,135","journal-title":"Virol J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/vbz.2013.1351","volume":"14","author":"Li W.","year":"2014","unstructured":"Li W.; Cao Y.; Fu S.; Wang J.; Li M.; Jiang S.; Wang X.; Xing S.; Feng L.; Wang Z.; Shi Y.; Zhao S.; Wang H.; Wang Z.; Liang G.; Tahyna virus infection, a neglected arboviral disease in the Qinghai-Tibet Plateau of China. Vector Borne Zoonotic Dis 2014,14(5),353-357","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3201\/eid1502.080722","volume":"15","author":"Lu Z.","year":"2009","unstructured":"Lu Z.; Lu X.J.; Fu S.H.; Zhang S.; Li Z.X.; Yao X.H.; Feng Y.P.; Lambert A.J.; Ni X.; Wang F.T.; Tong S.X.; Nasci R.S.; Feng Y.; Dong Q.; Zhai Y.G.; Gao X.Y.; Wang H.Y.; Tang Q.; Liang G.D.; Tahyna virus and human infection, China. Emerg Infect Dis 2009,15(2),306-309","journal-title":"Emerg Infect Dis"},{"key":"ref=65","author":"Pinheiro F.P.","year":"1994","unstructured":"Pinheiro F.P.; Travassos da Rosa A.P.; Handbook of Zoonoses 1994","journal-title":"Handbook of Zoonoses"},{"key":"ref=66","first-page":"1019","volume":"96","author":"Travassos da Rosa J.F.","year":"2017","unstructured":"Travassos da Rosa J.F.; de Souza W.M.; Pinheiro F.P.; Figueiredo M.L.; Cardoso J.F.; Acrani G.O.; Nunes M.R.T.; Oropouche virus: clinical, epidemiological, and molecular aspects of a neglected orthobunyavirus. Am J Trop Med Hyg 2017,96(5),1019-1030","journal-title":"Am J Trop Med Hyg"},{"key":"ref=67","year":"2016.","unstructured":"World Health Organization. Oropouche virus disease \u2013 Peru Available from: (Accessed on 24th November, 2018).2016."},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4269\/ajtmh.1981.30.149","volume":"30","author":"Pinheiro F.P.","year":"1981","unstructured":"Pinheiro F.P.; Travassos da Rosa A.P.; Travassos da Rosa J.F.; Ishak R.; Freitas R.B.; Gomes M.L.; LeDuc J.W.; Oliva O.F.; Oropouche virus. I. A review of clinical, epidemiological, and ecological findings. Am J Trop Med Hyg 1981,30(1),149-160","journal-title":"Am J Trop Med Hyg"},{"key":"ref=69","author":"European C.D.C.","year":"2019","unstructured":"European C.D.C.; Facts about hantavirus Available from: (Accessed on 25th November, 2018).2019"},{"key":"ref=70","year":"2017","unstructured":"CDC. Reported cases of hantavirus disease Available from: (Accessed on: 25th November, 2018).2017"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/0255-0857.53215","volume":"27","author":"Chandy S.","year":"2009","unstructured":"Chandy S.; Boorugu H.; Chrispal A.; Thomas K.; Abraham P.; Sridharan G.; Hantavirus infection: a case report from India. Indian J Med Microbiol 2009,27(3),267-270","journal-title":"Indian J Med Microbiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/rmv.1980040304","volume":"4","author":"Lundkvist A.","year":"1994","unstructured":"Lundkvist A.; Niklasson B.; Hemorrhagic fever with renal syndrome and other hantavirus infections. Rev Med Virol 1994,4,177-184","journal-title":"Rev Med Virol"},{"key":"ref=73","author":"M.S.D. Manuals","year":"2018","unstructured":"M.S.D. Manuals; Hantavirus Infection Available from: (Accessed on 25th November, 2018).2018"},{"key":"ref=74","year":"2018","unstructured":"World Health Organization. Zika virus Available from: (Accessed on 25th November, 2018).2018"},{"key":"ref=75","year":"2016","unstructured":"World Health Organization. Laboratory testing for Zika virus infection. Available from: (Accessed on 25th November, 2018).2016"},{"key":"ref=76","year":"2018","unstructured":"CDC. Zika virus Available from: (Accessed on, 25th November, 2018).2018"},{"key":"ref=77","year":"2017","unstructured":"World Health Organization. West Nile virus Available from: (Accessed on 25th November, 2018).2017"},{"key":"ref=78","year":"2018","unstructured":"CDC. West Nile virus Available from: (Accessed on: 25th November, 2018).2018"},{"key":"ref=79","author":"Murphy F.","year":"1991","unstructured":"Murphy F.; Gibbs E.; Horzinek M.; Studdert M.; Veterinary Virology 1991","journal-title":"Veterinary Virology"},{"key":"ref=80","year":"2018","unstructured":"European Centre for Disease Prevention and Control. West Nile fever Available from: (Accessed on 25th November, 2018).2018"},{"key":"ref=81","year":"2019","unstructured":"Centers for Disease Control and Prevention. Preliminary Maps"},{"key":"ref=82","year":"2019","unstructured":"WHO. Collaborating centre for drug statistics methodology Available from: (Accessed on 25th November, 2018).2019"},{"key":"ref=83","year":"2018","unstructured":"CDC. Saint louis encephalitis Available from: (Accessed on 25th November, 2018).2018"},{"key":"ref=84","year":"2014","unstructured":"CDC. Tick-borne Encephalitis (TBE) Available from: (Accessed on 25th November, 2018).2014"},{"key":"ref=85","year":"2019","unstructured":"World Health Organization. Tick-borne encephalitis Available from: (Accessed on 25th November, 2018).2019"},{"key":"ref=86","year":"2019","unstructured":"CDC. Dengue Available from: (Accessed on 25th November, 2018).2019"},{"key":"ref=87","year":"2019","unstructured":"World Health Organization. Dengue control Available from: (Accessed on 25th November, 2018).2019"},{"key":"ref=88","year":"2019","unstructured":"CDC. Yellow Fever Available from: (Accessed on 25th November, 2018).2019"},{"key":"ref=89","year":"2018","unstructured":"World Health Organization. Yellow fever Available from: (Accessed on 25th November, 2018).2018"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1525\/maq.1987.1.4.02a00040","volume":"1","author":"Nichter M.","year":"1987","unstructured":"Nichter M.; Kyasanur forest disease: an ethnography of a disease of development. Med Anthropol Q 1987,1(4),406-423","journal-title":"Med Anthropol Q"},{"key":"ref=91","year":"2016","unstructured":"National Health Portal. Kyasanur forest disease Available from: (Accessed on:25th November, 2018).2016"},{"key":"ref=92","year":"2014","unstructured":"CDC. Kyasanur Forest Disease (KFD), Available from:(Accessed on 25th November, 2018).2014"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.antiviral.2012.10.005","volume":"96","author":"Holbrook M.R.","year":"2012","unstructured":"Holbrook M.R.; Kyasanur forest disease. Antiviral Res 2012,96(3),353-362","journal-title":"Antiviral Res"},{"key":"ref=94","year":"2018","unstructured":"Sitata Inc. Kyasanur Forest Disease Vaccine CDC Available from: (Accessed on 25th November, 2018).2018"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2471\/BLT.10.085233","volume":"89","author":"Campbell G.L.","year":"2011","unstructured":"Campbell G.L.; Hills S.L.; Fischer M.; Jacobson J.A.; Hoke C.H.; Hombach J.M.; Marfin A.A.; Solomon T.; Tsai T.F.; Tsu V.D.; Ginsburg A.S.; Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011,89(10),766-774, 774A-774E","journal-title":"Bull World Health Organ"},{"key":"ref=96","author":"Park K.","year":"2015","unstructured":"Park K.; Park\u2019s textbook of preventive and social medicine 2015","journal-title":"Park\u2019s textbook of preventive and social medicine"},{"key":"ref=97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000437","volume":"3","author":"Ghosh D.","year":"2009","unstructured":"Ghosh D.; Basu A.; Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis 2009,3(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=98","year":"2017","unstructured":"CDC. Infectious Diseases Related to Travel Available from: (Accessed on 27th November, 2018).2017"},{"key":"ref=99","year":"2015","unstructured":"World Health Organization. Japanese encephalitis Available from: (Accessed on 27th November, 2018).2015"},{"key":"ref=100","year":"2015","unstructured":"CDC. Japanese Encephalitis Available from: (Accessed on 27th November, 2018).2015"},{"key":"ref=101","volume":"3","author":"Schi\u00f8ler K.L.","year":"2007","unstructured":"Schi\u00f8ler K.L.; Samuel M.; Wai K.L.; Vaccines for preventing Japanese encephalitis. Cochrane Database Syst Rev 2007,3(3)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.74.1913.227","volume":"74","author":"Meyer K.F.","year":"1931","unstructured":"Meyer K.F.; Haring C.M.; Howitt B.; The etiology of epizootic encephalomyelitis of horses in the san joaquin valley, 1930. Science 1931,74(1913),227-228","journal-title":"Science"},{"key":"ref=103","year":"2018","unstructured":"CDC. Eastern equine encephalitis Available from: (Accessed on 27th November, 2018).2018"},{"key":"ref=104","year":"2018","unstructured":"CDC. Chikungunya Virus Available from: (Accessed on 27th November, 2018).2018"},{"key":"ref=105","year":"2017","unstructured":"World Health Organization. Chikungunya (Accessed on 27th November, 2018).2017"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-ento-031616-035010","volume":"62","author":"Carpenter S.","year":"2017","unstructured":"Carpenter S.; Mellor P.S.; Fall A.G.; Garros C.; Venter G.J.; African horse sickness virus: history, transmission, and current status. Annu Rev Entomol 2017,62,343-358","journal-title":"Annu Rev Entomol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3201\/eid2212.160718","volume":"22","author":"Weyer C.T.","year":"2016","unstructured":"Weyer C.T.; Grewar J.D.; Burger P.; Rossouw E.; Lourens C.; Joone C.; le Grange M.; Coetzee P.; Venter E.; Martin D.P.; MacLachlan N.J.; Guthrie A.J.; African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014. Emerg Infect Dis 2016,22(12),2087-2096","journal-title":"Emerg Infect Dis"},{"key":"ref=108","year":"2018","unstructured":"Colorado Tick-Borne Disease Awareness Association. Colorado tick fever Available from: (Accessed on 27th November, 2018).2018"},{"key":"ref=109","year":"2018","unstructured":"Centers for Disease Control and Prevention. Colorado Tick Fever (CTF) Available from: (Accessed on 27th November, 2018).2018"},{"key":"ref=110","year":"2018","unstructured":"World Health Organization. Rabies Available from: (Accessed on 27th November, 2018).2018"},{"key":"ref=111","year":"2016","unstructured":"Centers for Disease Control and Prevention. Rabies Available from: (Accessed on 27th November, 2018).2016"},{"key":"ref=112","first-page":"360","volume":"83","author":"Knobel D.L.","year":"2005","unstructured":"Knobel D.L.; Cleaveland S.; Coleman P.G.; F\u00e8vre E.M.; Meltzer M.I.; Miranda M.E.; Shaw A.; Zinsstag J.; Meslin F.X.; Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005,83(5),360-368","journal-title":"Bull World Health Organ"},{"key":"ref=113","first-page":"185","author":"Wilde H.","year":"2013","unstructured":"Wilde H.; Hemachudha T.; Wacharapluesadee S.; Lumlertdacha B.; Tepsumethanon V.; One health: the human-animal-environment interfaces in emerging infectious diseases 2013,185","journal-title":"One health: the human-animal-environment interfaces in emerging infectious diseases"},{"key":"ref=114","year":"2005","unstructured":"WHO Expert Consultation on Rabies: first report WHO Expert Consultation on Rabies","journal-title":"WHO Expert Consultation on Rabies: first report"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11908-012-0268-2","volume":"14","author":"Feder H.M.","year":"2012","unstructured":"Feder H.M.; Petersen B.W.; Robertson K.L.; Rupprecht C.E.; Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts. Curr Infect Dis Rep 2012,14(4),408-422","journal-title":"Curr Infect Dis Rep"},{"key":"ref=116","year":"2013","unstructured":"Centers for Disease Control and Prevention. Vaccine Information statements. Vaccine Information Statements (VISs) Available from: (Accessed on 27th November, 2018).2013"},{"key":"ref=117","year":"2012","unstructured":"Animal and Plant Health Inspection Service Veterinary Services. Vesicular stomatitis Available from: (Accessed on 27th November, 2018).2012"},{"key":"ref=118","year":"2006","unstructured":"The Center for Food Security and Public Health. Vesicular stomatitis Available from: (Accessed on 27th November, 2018).2006"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3201\/eid2102.141649","volume":"21","author":"Marzi A.","year":"2015","unstructured":"Marzi A.; Feldmann F.; Geisbert T.W.; Feldmann H.; Safronetz D.; Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses. Emerg Infect Dis 2015,21(2),305-307","journal-title":"Emerg Infect Dis"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3201\/eid0911.020814","volume":"9","author":"Pelkonen P.M.","year":"2003","unstructured":"Pelkonen P.M.; Tarvainen K.; Hynninen A.; Kallio E.R.K.; Henttonen K.; Palva A.; Vaheri A.; Vapalahti O.; Cowpox with severe generalized eruption, Finland. Emerg Infect Dis 2003,9(11),1458-1461","journal-title":"Emerg Infect Dis"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","volume":"67","author":"Durski K.N.","year":"2018","unstructured":"Durski K.N.; McCollum A.M.; Nakazawa Y.; Petersen B.W.; Reynolds M.G.; Briand S.; Djingarey M.H.; Olson V.; Damon I.K.; Khalakdina A.; Emergence of Monkeypox - West and Central Africa, 1970-2017. MMWR Morb Mortal Wkly Rep 2018,67(10),306-310","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"McCollum A.M.","year":"2014","unstructured":"McCollum A.M.; Damon I.K.; Human monkeypox. Clin Infect Dis 2014,58(2),260-267","journal-title":"Clin Infect Dis"},{"key":"ref=123","year":"2019","unstructured":"World Health Organization. Human Monkeypox (MPX) Available from: (Accessed on 27th November, 2018).2019"},{"key":"ref=124","year":"2018","unstructured":"World Health Organization. Monkeypox Available from: (Accessed on 27th November, 2018).2018"},{"key":"ref=125","year":"2015","unstructured":"Centers for Disease Control and Prevention. Monkeypox Available from: (Accessed on 27th November, 2018).2015"},{"key":"ref=126","author":"Kradin R.L.","year":"2018","unstructured":"Kradin R.L.; Diagnostic Pathology of Infectious Disease 2018","journal-title":"Diagnostic Pathology of Infectious Disease"},{"key":"ref=127","author":"Cohen J.","year":"2018","unstructured":"Cohen J.; Powderly W.G.; Opal S.M.; Infectious Diseases 2018","journal-title":"Infectious Diseases"},{"key":"ref=128","year":"2015","unstructured":"Centers for Disease Control and Prevention. Orf Virus (Sore Mouth Infection) CDC Available from: (Accessed on 27th November, 2018).2015"},{"key":"ref=129","year":"2016","unstructured":"National Health Service (NHS). Orf Available from: (Accessed on 27th November, 2018).2016"},{"key":"ref=130","year":"2014","unstructured":"Centers for Disease Control and Prevention. B Virus (herpes B,monkey B virus, herpesvirus simiae, and herpesvirus B) Available from: (27th November, 2018).2014"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/344754","volume":"35","author":"Cohen J.I.","year":"2002","unstructured":"Cohen J.I.; Davenport D.S.; Stewart J.A.; Deitchman S.; Hilliard J.K.; Chapman L.E.; Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis 2002,35(10),1191-1203","journal-title":"Clin Infect Dis"},{"key":"ref=132","year":"2014","unstructured":"Centers for Disease Control and Prevention. Lymphocytic Choriomeningitis (LCM) Available from: (Accessed on 27th November, 2018).2014"},{"key":"ref=133","year":"2015","unstructured":"Centers for Disease Control and Prevention. Lassa fever Available from: (Accessed on 27th November, 2018).2015"},{"key":"ref=134","year":"2017","unstructured":"World Health Organization. Lassa fever Available from: (Accessed on 27th November, 2018).2017"},{"key":"ref=135","year":"2013","unstructured":"OIE - World Organisation for Animal Health. Foot and Mouth Disease Available from: (Accessed on 28th November, 2018).2013"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coviro.2017.11.013","volume":"28","author":"Paton D.J.","year":"2018","unstructured":"Paton D.J.; Gubbins S.; King D.P.; Understanding the transmission of foot-and-mouth disease virus at different scales. Curr Opin Virol 2018,28,85-91","journal-title":"Curr Opin Virol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1126\/science.102.2637.31","volume":"102","author":"Helwig F.C.","year":"1945","unstructured":"Helwig F.C.; Schmidt C.H.; A filter-passing agent producing interstitial myocarditis in anthropoid apes and small animals. Science 1945,102(2637),31-33","journal-title":"Science"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/vbz.2010.0029","volume":"11","author":"Czechowicz J.","year":"2011","unstructured":"Czechowicz J.; Huaman J.L.; Forshey B.M.; Morrison A.C.; Castillo R.; Huaman A.; Caceda R.; Eza D.; Rocha C.; Blair P.J.; Olson J.G.; Kochel T.J.; Prevalence and risk factors for encephalomyocarditis virus infection in Peru. Vector Borne Zoonotic Dis 2011,11(4),367-374","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4161\/viru.20573","volume":"3","author":"Carocci M.","year":"2012","unstructured":"Carocci M.; Bakkali-Kassimi L.; The encephalomyocarditis virus. Virulence 2012,3(4),351-367","journal-title":"Virulence"},{"key":"ref=140","year":"2017","unstructured":"Centers for Disease Control and Prevention. Severe Acute Respiratory Syndrome (SARS) CDC Available from: (Accessed on 28th November, 2018).2017"},{"key":"ref=141","year":"2019","unstructured":"World Health Organization. Severe Acute Respiratory Syndrome (SARS) WHO Available from: (Accessed on 28th November, 2018).2019"},{"key":"ref=142","year":"2017","unstructured":"Centers for Disease Control and Prevention. Middle East Respiratory Syndrome (MERS) CDC Available from: (Accessed on 28th November, 2018).2017"},{"key":"ref=143","year":"2019","unstructured":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) Available from: (Accessed on 28th November, 2018).2019"},{"key":"ref=144","year":"2018","unstructured":"World Health Organization. WHO MERS Global Summary and Assessment of Risk Available from: (Accessed on 28th November, 2018).2018"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.antiviral.2018.09.002","volume":"159","year":"2018","unstructured":"MERS: Progress on the global response, remaining challenges and the way forward. Antiviral Res 2018,159,35-44","journal-title":"Antiviral Res"},{"key":"ref=146","year":"2019","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Available from: (Accessed on 29th November, 2018).2019"},{"key":"ref=147","year":"2019","unstructured":"World Health Organization. Global Influenza Surveillance and Response System (GISRS) Available from: (Accessed on 29th November, 2018).2019"},{"key":"ref=148","year":"2017","unstructured":"Centers for Disease Control and Prevention. National Pandemic Strategy Available from: (Accessed on 29th November, 2018).2017"},{"key":"ref=149","year":"2019","unstructured":"World Health Organization. Influenza Available from: (Accessed on 29th November, 2018).2019"},{"key":"ref=150","year":"2018","unstructured":"Centers for Disease Control and Prevention. Nipah Virus (NiV) Available from: (Accessed on 9th November, 2018).2018"},{"key":"ref=151","year":"2013","unstructured":"United States Department of Agriculture. Newcastle disease standard operating procedures, Overview of etiology and ecology Available from: (Accessed on 29th November, 2018).2013"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"12709","DOI":"10.1128\/JVI.01406-07","volume":"81","author":"Goebel S.J.","year":"2007","unstructured":"Goebel S.J.; Taylor J.; Barr B.C.; Kiehn T.E.; Castro-Malaspina H.R.; Hedvat C.V.; Rush-Wilson K.A.; Kelly C.D.; Davis S.W.; Samsonoff W.A.; Hurst K.R.; Behr M.J.; Masters P.S.; Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia. J Virol 2007,81(22),12709-12714","journal-title":"J Virol"},{"key":"ref=153","year":"2012","unstructured":"Illinois Department of Public Health. Human health concerns about raising poultry Available from: (Accessed on: 29th November, 2018).2012"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.2460\/javma.2003.222.1534","volume":"222","author":"Swayne D.E.","year":"2003","unstructured":"Swayne D.E.; King D.J.; Avian influenza and Newcastle disease. J Am Vet Med Assoc 2003,222(11),1534-1540","journal-title":"J Am Vet Med Assoc"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"Kamar N.","year":"2014","unstructured":"Kamar N.; Dalton H.R.; Abravanel F.; Izopet J.; Hepatitis E virus infection. Clin Microbiol Rev 2014,27(1),116-138","journal-title":"Clin Microbiol Rev"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1051\/vetres\/2010018","volume":"41","author":"Pavio N.","year":"2010","unstructured":"Pavio N.; Meng X.J.; Renou C.; Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet Res 2010,41(6),46","journal-title":"Vet Res"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1746-6148-3-9","volume":"3","author":"Satou K.","year":"2007","unstructured":"Satou K.; Nishiura H.; Transmission dynamics of hepatitis E among swine: potential impact upon human infection. BMC Vet Res 2007,3,9","journal-title":"BMC Vet Res"},{"key":"ref=158","year":"2018","unstructured":"World Health Organization. Hepatitis E Available from: (Accessed on 29th November, 2018).2018"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","volume":"11","author":"Li S.W.","year":"2015","unstructured":"Li S.W.; Zhao Q.; Wu T.; Chen S.; Zhang J.; Xia N.S.; The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother 2015,11(4),908-914","journal-title":"Hum Vaccin Immunother"},{"key":"ref=160","first-page":"997","volume":"61","author":"Baron R.C.","year":"1983","unstructured":"Baron R.C.; McCormick J.B.; Zubeir O.A.; Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 1983,61(6),997-1003","journal-title":"Bull World Health Organ"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","volume":"78","author":"Towner J.S.","year":"2004","unstructured":"Towner J.S.; Rollin P.E.; Bausch D.G.; Sanchez A.; Crary S.M.; Vincent M.; Lee W.F.; Spiropoulou C.F.; Ksiazek T.G.; Lukwiya M.; Kaducu F.; Downing R.; Nichol S.T.; Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004,78(8),4330-4341","journal-title":"J Virol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3201\/eid1612.100627","volume":"16","author":"MacNeil A.","year":"2010","unstructured":"MacNeil A.; Farnon E.C.; Wamala J.; Okware S.; Cannon D.L.; Reed Z.; Towner J.S.; Tappero J.W.; Lutwama J.; Downing R.; Nichol S.T.; Ksiazek T.G.; Rollin P.E.; Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis 2010,16(12),1969-1972","journal-title":"Emerg Infect Dis"},{"key":"ref=163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000212","volume":"4","author":"Towner J.S.","year":"2008","unstructured":"Towner J.S.; Sealy T.K.; Khristova M.L.; Albari\u00f1o C.G.; Conlan S.; Reeder S.A.; Quan P.L.; Lipkin W.I.; Downing R.; Tappero J.W.; Okware S.; Lutwama J.; Bakamutumaho B.; Kayiwa J.; Comer J.A.; Rollin P.E.; Ksiazek T.G.; Nichol S.T.; Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 2008,4(11)","journal-title":"PLoS Pathog"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3201\/eid1607.091525","volume":"16","author":"Wamala J.F.","year":"2010","unstructured":"Wamala J.F.; Lukwago L.; Malimbo M.; Nguku P.; Yoti Z.; Musenero M.; Amone J.; Mbabazi W.; Nanyunja M.; Zaramba S.; Opio A.; Lutwama J.J.; Talisuna A.O.; Okware S.I.; Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis 2010,16(7),1087-1092","journal-title":"Emerg Infect Dis"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1128\/JVI.00069-06","volume":"80","author":"Towner J.S.","year":"2006","unstructured":"Towner J.S.; Khristova M.L.; Sealy T.K.; Vincent M.J.; Erickson B.R.; Bawiec D.A.; Hartman A.L.; Comer J.A.; Zaki S.R.; Str\u00f6her U.; Gomes da Silva F.; del Castillo F.; Rollin P.E.; Ksiazek T.G.; Nichol S.T.; Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006,80(13),6497-6516","journal-title":"J Virol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3201\/eid0912.030355","volume":"9","author":"Bausch D.G.","year":"2003","unstructured":"Bausch D.G.; Borchert M.; Grein T.; Roth C.; Swanepoel R.; Libande M.L.; Talarmin A.; Bertherat E.; Muyembe-Tamfum J.J.; Tugume B.; Colebunders R.; Kond\u00e9 K.M.; Pirad P.; Olinda L.L.; Rodier G.R.; Campbell P.; Tomori O.; Ksiazek T.G.; Rollin P.E.; Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis 2003,9(12),1531-1537","journal-title":"Emerg Infect Dis"},{"key":"ref=167","year":"2018","unstructured":"World Health Organization. Ebola virus disease WHO. Available from: (Accessed on 29th November, 2018).2018"},{"key":"ref=168","year":"2014","unstructured":"Centers for Disease Control and Prevention. Marburg hemorrhagic fever (Marburg HF) CDC Available from: (Accessed on 29th November, 2018).2014"},{"key":"ref=169","year":"2018","unstructured":"Centers for Disease Control and Prevention. Viral Hemorrhagic Fevers (VHFs) CDC Available from: (Accessed on 29th November, 2018).2018"},{"key":"ref=170","year":"2017","unstructured":"U.S. National Library of Medicine. Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda Available from: (Accessed on 29th November, 2018).2017"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"S1066","DOI":"10.1093\/infdis\/jir348","volume":"204","author":"Marzi A.","year":"2011","unstructured":"Marzi A.; Ebihara H.; Callison J.; Groseth A.; Williams K.J.; Geisbert T.W.; Feldmann H.; Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis 2011,204(Suppl. 3),S1066-S1074","journal-title":"J Infect Dis"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"Henao-Restrepo A.M.","year":"2017","unstructured":"Henao-Restrepo A.M.; Camacho A.; Longini I.M.; Watson C.H.; Edmunds W.J.; Egger M.; Carroll M.W.; Dean N.E.; Diatta I.; Doumbia M.; Draguez B.; Duraffour S.; Enwere G.; Grais R.; Gunther S.; Gsell P.S.; Hossmann S.; Watle S.V.; Kond\u00e9 M.K.; K\u00e9\u00efta S.; Kone S.; Kuisma E.; Levine M.M.; Mandal S.; Mauget T.; Norheim G.; Riveros X.; Soumah A.; Trelle S.; Vicari A.S.; R\u00f8ttingen J.A.; Kieny M.P.; Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!). Lancet 2017,389(10068),505-518","journal-title":"Lancet"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/B978-0-323-52733-0.00002-1","author":"Kulshreshtha N.M.","year":"2017","unstructured":"Kulshreshtha N.M.; Jadhav I.; Dixit M.; Sinha N.; Shrivastava D.; Bisen P.S.; Nanostructures as antimicrobial therapeutics antimicrobial nanoarchitectonics 2017,29-59","journal-title":"Nanostructures as antimicrobial therapeutics antimicrobial nanoarchitectonics"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40121-013-0014-6","volume":"2","author":"Lien G.","year":"2013","unstructured":"Lien G.; Heymann D.L.; The problems with polio: toward eradication. Infect Dis Ther 2013,2(2),167-174","journal-title":"Infect Dis Ther"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.vaccine.2017.01.031","volume":"35","author":"Chappuis F.","year":"2017","unstructured":"Chappuis F.; Farinelli T.; Deckx H.; Sarnecki M.; Go O.; Salzgeber Y.; Stals C.; Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study. Vaccine 2017,35(10),1448-1454","journal-title":"Vaccine"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12885-018-4033-2","volume":"18","author":"Paz-Zulueta M.","year":"2018","unstructured":"Paz-Zulueta M.; \u00c1lvarez-Paredes L.; Rodr\u00edguez D\u00edaz J.C.; Par\u00e1s-Bravo P.; Andrada Becerra M.E.; Rodr\u00edguez Ingelmo J.M.; Ruiz Garc\u00eda M.M.; Portilla J.; Santiba\u00f1ez M.; Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC Cancer 2018,18(1),112","journal-title":"BMC Cancer"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.vaccine.2018.01.065","volume":"36","author":"Pezzotti P.","year":"2018","unstructured":"Pezzotti P.; Bellino S.; Prestinaci F.; Iacchini S.; Lucaroni F.; Camoni L.; Barbieri M.M.; Ricciardi W.; Stefanelli P.; Rezza G.; The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015. Vaccine 2018,36(11),1435-1443","journal-title":"Vaccine"},{"key":"ref=178","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2012.0939","volume":"10","author":"Treuel L.","year":"2013","unstructured":"Treuel L.; Jiang X.; Nienhaus G.U.; New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 2013,10(82)","journal-title":"J R Soc Interface"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fimmu.2018.02224","volume":"9","author":"Pati R.","year":"2018","unstructured":"Pati R.; Shevtsov M.; Sonawane A.; Nanoparticle vaccines against infectious diseases. Front Immunol 2018,9,16","journal-title":"Front Immunol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s12038-009-0114-3","volume":"34","author":"Nandedkar T.D.","year":"2009","unstructured":"Nandedkar T.D.; Nanovaccines: recent developments in vaccination. J Biosci 2009,34(6),995-1003","journal-title":"J Biosci"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","volume":"60","author":"Peek L.J.","year":"2008","unstructured":"Peek L.J.; Middaugh C.R.; Berkland C.; Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 2008,60(8),915-928","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"Zhao L.","year":"2014","unstructured":"Zhao L.; Seth A.; Wibowo N.; Zhao C.X.; Mitter N.; Yu C.; Middelberg A.P.; Nanoparticle vaccines. Vaccine 2014,32(3),327-337","journal-title":"Vaccine"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-3155-9-55","volume":"9","author":"Mahapatro A.","year":"2011","unstructured":"Mahapatro A.; Singh D.K.; Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology 2011,9,55","journal-title":"J Nanobiotechnology"},{"key":"ref=184","doi-asserted-by":"publisher","DOI":"10.1063\/1.3276915","volume":"131","author":"Chiu C.C.","year":"2009","unstructured":"Chiu C.C.; Moore P.B.; Shinoda W.; Nielsen S.O.; Size-dependent hydrophobic to hydrophilic transition for nanoparticles: a molecular dynamics study. J Chem Phys 2009,131(24)","journal-title":"J Chem Phys"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/en.2009-1082","volume":"151","author":"Zolnik B.S.","year":"2010","unstructured":"Zolnik B.S.; Gonz\u00e1lez-Fern\u00e1ndez A.; Sadrieh N.; Dobrovolskaia M.A.; Nanoparticles and the immune system. Endocrinology 2010,151(2),458-465","journal-title":"Endocrinology"},{"key":"ref=186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018319","volume":"6","author":"Arama C.","year":"2011","unstructured":"Arama C.; Giusti P.; Bostr\u00f6m S.; Dara V.; Traore B.; Dolo A.; Doumbo O.; Varani S.; Troye-Blomberg M.; Interethnic differences in antigen-presenting cell activation and TLR responses in Malian children during Plasmodium falciparum malaria. PLoS One 2011,6(3)","journal-title":"PLoS One"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/hv.26796","volume":"10","author":"Bolhassani A.","year":"2014","unstructured":"Bolhassani A.; Javanzad S.; Saleh T.; Hashemi M.; Aghasadeghi M.R.; Sadat S.M.; Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases. Hum Vaccin Immunother 2014,10(2),321-332","journal-title":"Hum Vaccin Immunother"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-1-4939-6646-2_15","volume":"1530","author":"Alshamsan A.","year":"2017","unstructured":"Alshamsan A.; Nanotechnology-Based Cancer Vaccine. Methods Mol Biol 2017,1530,257-270","journal-title":"Methods Mol Biol"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejpb.2011.10.016","volume":"80","author":"Wadhwa S.","year":"2012","unstructured":"Wadhwa S.; Jain A.; Woodward J.G.; Mumper R.J.; Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responses. Eur J Pharm Biopharm 2012,80(2),315-322","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1021\/nn304235j","volume":"7","author":"Zaric M.","year":"2013","unstructured":"Zaric M.; Lyubomska O.; Touzelet O.; Poux C.; Al-Zahrani S.; Fay F.; Wallace L.; Terhorst D.; Malissen B.; Henri S.; Power U.F.; Scott C.J.; Donnelly R.F.; Kissenpfennig A.; Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano 2013,7(3),2042-2055","journal-title":"ACS Nano"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/erv.11.17","volume":"10","author":"Christensen D.","year":"2011","unstructured":"Christensen D.; Korsholm K.S.; Andersen P.; Agger E.M.; Cationic liposomes as vaccine adjuvants. Expert Rev Vaccines 2011,10(4),513-521","journal-title":"Expert Rev Vaccines"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","volume":"12","author":"Silva A.L.","year":"2016","unstructured":"Silva A.L.; Soema P.C.; Sl\u00fctter B.; Ossendorp F.; Jiskoot W.; PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity. Hum Vaccin Immunother 2016,12(4),1056-1069","journal-title":"Hum Vaccin Immunother"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nmat2960","volume":"10","author":"Moon J.J.","year":"2011","unstructured":"Moon J.J.; Suh H.; Bershteyn A.; Stephan M.T.; Liu H.; Huang B.; Sohail M.; Luo S.; Um S.H.; Khant H.; Goodwin J.T.; Ramos J.; Chiu W.; Irvine D.J.; Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater 2011,10(3),243-251","journal-title":"Nat Mater"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.biotechadv.2015.05.010","volume":"33","author":"Cordeiro A.S.","year":"2015","unstructured":"Cordeiro A.S.; Alonso M.J.; de la Fuente M.; Nanoengineering of vaccines using natural polysaccharides. Biotechnol Adv 2015,33(6 Pt 3),1279-1293","journal-title":"Biotechnol Adv"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5501\/wjv.v4.i3.156","volume":"4","author":"Trovato M.","year":"2015","unstructured":"Trovato M.; De Berardinis P.; Novel antigen delivery systems. World J Virol 2015,4(3),156-168","journal-title":"World J Virol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1440-1711.2005.01319.x","volume":"83","author":"Sanders M.T.","year":"2005","unstructured":"Sanders M.T.; Brown L.E.; Deliyannis G.; Pearse M.J.; ISCOM-based vaccines: the second decade. Immunol Cell Biol 2005,83(2),119-128","journal-title":"Immunol Cell Biol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s00705-018-3856-0","volume":"163","author":"Sulczewski F.B.","year":"2018","unstructured":"Sulczewski F.B.; Liszbinski R.B.; Rom\u00e3o P.R.T.; Rodrigues Junior L.C.; Nanoparticle vaccines against viral infections. Arch Virol 2018,163(9),2313-2325","journal-title":"Arch Virol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ajps.2014.06.002","volume":"9","author":"Kim M.G.","year":"2014","unstructured":"Kim M.G.; Park J.Y.; Shon Y.; Kim G.; Shim G.; Oh Y.K.; Nanotechnology and vaccine development. Asian J Pharma Sci 2014,9(5),227-235","journal-title":"Asian J Pharma Sci"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fimmu.2018.00345","volume":"9","author":"Gao Y.","year":"2018","unstructured":"Gao Y.; Wijewardhana C.; Mann J.F.S.; Virus-like particle, liposome, and polymeric particle-based vaccines against HIV-1. Front Immunol 2018,9,345","journal-title":"Front Immunol"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/bit.26890","volume":"116","author":"Charlton Hume H.K.","year":"2019","unstructured":"Charlton Hume H.K.; Vidigal J.; Carrondo M.J.T.; Middelberg A.P.J.; Rold\u00e3o A.; Lua L.H.L.; Synthetic biology for bioengineering virus-like particle vaccines. Biotechnol Bioeng 2019,116(4),919-935","journal-title":"Biotechnol Bioeng"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.fsi.2019.05.017","volume":"91","author":"Kole S.","year":"2019","unstructured":"Kole S.; Qadiri S.S.N.; Shin S.M.; Kim W.S.; Lee J.; Jung S.J.; Nanoencapsulation of inactivated-viral vaccine using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in olive flounder (Paralichthys olivaceus) against viral haemorrhagic septicaemia virus (VHSV) infection. Fish Shellfish Immunol 2019,91,136-147","journal-title":"Fish Shellfish Immunol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","volume":"14","author":"L\u00f3pez-Sagaseta J.","year":"2015","unstructured":"L\u00f3pez-Sagaseta J.; Malito E.; Rappuoli R.; Bottomley M.J.; Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J 2015,14,58-68","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1126\/science.6272395","volume":"214","author":"Kleid D.G.","year":"1981","unstructured":"Kleid D.G.; Yansura D.; Small B.; Dowbenko D.; Moore D.M.; Grubman M.J.; McKercher P.D.; Morgan D.O.; Robertson B.H.; Bachrach H.L.; Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 1981,214(4525),1125-1129","journal-title":"Science"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/298347a0","volume":"298","author":"Valenzuela P.","year":"1982","unstructured":"Valenzuela P.; Medina A.; Rutter W.J.; Ammerer G.; Hall B.D.; Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982,298(5872),347-350","journal-title":"Nature"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","volume":"33","author":"Liu Y.V.","year":"2015","unstructured":"Liu Y.V.; Massare M.J.; Pearce M.B.; Sun X.; Belser J.A.; Maines T.R.; Creager H.M.; Glenn G.M.; Pushko P.; Smith G.E.; Tumpey T.M.; Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets. Vaccine 2015,33(18),2152-2158","journal-title":"Vaccine"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1016\/S0264-410X(02)00260-8","volume":"20","author":"Yusibov V.","year":"2002","unstructured":"Yusibov V.; Hooper D.C.; Spitsin S.V.; Fleysh N.; Kean R.B.; Mikheeva T.; Deka D.; Karasev A.; Cox S.; Randall J.; Koprowski H.; Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002,20(25-26),3155-3164","journal-title":"Vaccine"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMc1313186","volume":"369","author":"Fries L.F.","year":"2013","unstructured":"Fries L.F.; Smith G.E.; Glenn G.M.; A recombinant viruslike particle influenza A (H7N9) vaccine. N Engl J Med 2013,369(26),2564-2566","journal-title":"N Engl J Med"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"Kanekiyo M.","year":"2015","unstructured":"Kanekiyo M.; Bu W.; Joyce M.G.; Meng G.; Whittle J.R.; Baxa U.; Yamamoto T.; Narpala S.; Todd J.P.; Rao S.S.; McDermott A.B.; Koup R.A.; Rossmann M.G.; Mascola J.R.; Graham B.S.; Cohen J.I.; Nabel G.J.; Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell 2015,162(5),1090-1100","journal-title":"Cell"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/349541a0","volume":"349","author":"Lawson D.M.","year":"1991","unstructured":"Lawson D.M.; Artymiuk P.J.; Yewdall S.J.; Smith J.M.; Livingstone J.C.; Treffry A.; Luzzago A.; Levi S.; Arosio P.; Cesareni G.; Thomas C.D.; Shaw W.V.; Harrison P.M.; Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 1991,349(6309),541-544","journal-title":"Nature"},{"key":"ref=210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050852","volume":"7","author":"Smith G.","year":"2012","unstructured":"Smith G.; Raghunandan R.; Wu Y.; Liu Y.; Massare M.; Nathan M.; Zhou B.; Lu H.; Boddapati S.; Li J.; Flyer D.; Glenn G.; Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats. PLoS One 2012,7(11)","journal-title":"PLoS One"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/infdis\/jiv406","volume":"213","author":"Glenn G.M.","year":"2016","unstructured":"Glenn G.M.; Fries L.F.; Thomas D.N.; Smith G.; Kpamegan E.; Lu H.; Flyer D.; Jani D.; Hickman S.P.; Piedra P.A.; A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age. J Infect Dis 2016,213(3),411-422","journal-title":"J Infect Dis"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","volume":"20","author":"Mischler R.","year":"2002","unstructured":"Mischler R.; Metcalfe I.C.; Inflexal V a trivalent virosome subunit influenza vaccine: production. Vaccine 2002,20(Suppl. 5),B17-B23","journal-title":"Vaccine"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1875933500902010015","volume":"2","author":"Raman S.","year":"2009","unstructured":"Raman S.; Machaidze G.; Lustig A.; Olivieri V.; Aebi U.; Burkhard P.; Design of peptide nanoparticles using simple protein oligomerization domains. Open Nanomed J 2009,2,15-26","journal-title":"Open Nanomed J"},{"key":"ref=214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203771","volume":"13","author":"Li J.","year":"2018","unstructured":"Li J.; Self-adjuvanted nanoparticle based vaccines for poultry viral respiratory diseases. doctoral dissertations. PLoS One 2018,13(9)","journal-title":"PLoS One"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.4049\/jimmunol.1202654","volume":"190","author":"Knuschke T.","year":"2013","unstructured":"Knuschke T.; Sokolova V.; Rotan O.; Wadwa M.; Tenbusch M.; Hansen W.; Staeheli P.; Epple M.; Buer J.; Westendorf A.M.; Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. J Immunol 2013,190(12),6221-6229","journal-title":"J Immunol"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.2147\/IJN.S178809","volume":"13","author":"Dhakal S.","year":"2018","unstructured":"Dhakal S.; Cheng X.; Salcido J.; Renu S.; Bondra K.; Lakshmanappa Y.S.; Misch C.; Ghimire S.; Feliciano-Ruiz N.; Hogshead B.; Krakowka S.; Carson K.; McDonough J.; Lee C.W.; Renukaradhya G.J.; Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs. Int J Nanomedicine 2018,13,6699-6715","journal-title":"Int J Nanomedicine"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"E7758","DOI":"10.1073\/pnas.1805713115","volume":"115","author":"Deng L.","year":"2018","unstructured":"Deng L.; Chang T.Z.; Wang Y.; Li S.; Wang S.; Matsuyama S.; Yu G.; Compans R.W.; Li J.D.; Prausnitz M.R.; Champion J.A.; Wang B.Z.; Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice. Proc Natl Acad Sci USA 2018,115(33),E7758-E7767","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","volume":"176","author":"Marcandalli J.","year":"2019","unstructured":"Marcandalli J.; Fiala B.; Ols S.; Perotti M.; de van der Schueren W.; Snijder J.; Hodge E.; Benhaim M.; Ravichandran R.; Carter L.; Sheffler W.; Brunner L.; Lawrenz M.; Dubois P.; Lanzavecchia A.; Sallusto F.; Lee K.K.; Veesler D.; Correnti C.E.; Stewart L.J.; Baker D.; Lor\u00e9 K.; Perez L.; King N.P.; Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus. Cell 2019,176(6),1420-1431.e17","journal-title":"Cell"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","volume":"13","author":"Yusuf H.","year":"2017","unstructured":"Yusuf H.; Kett V.; Current prospects and future challenges for nasal vaccine delivery. Hum Vaccin Immunother 2017,13(1),34-45","journal-title":"Hum Vaccin Immunother"},{"key":"ref=220","unstructured":"NOVAVAX. Clinical Stage Pipeline. Available from: (Accessed on 25 November, 2018)."},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.addr.2009.11.014","volume":"62","author":"Tallury P.","year":"2010","unstructured":"Tallury P.; Malhotra A.; Byrne L.M.; Santra S.; Nanobioimaging and sensing of infectious diseases. Adv Drug Deliv Rev 2010,62(4-5),424-437","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.2147\/IJN.S137338","volume":"12","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Yu L.; Kong X.; Sun L.; Application of nanodiagnostics in point-of-care tests for infectious diseases. Int J Nanomedicine 2017,12,4789-4803","journal-title":"Int J Nanomedicine"},{"key":"ref=223","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700509","volume":"7","author":"Xu K.","year":"2018","unstructured":"Xu K.; Liang Z.C.; Ding X.; Hu H.; Liu S.; Nurmik M.; Bi S.; Hu F.; Ji Z.; Ren J.; Yang S.; Yang Y.Y.; Li L.; Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections. Adv Healthc Mater 2018,7(1)","journal-title":"Adv Healthc Mater"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1021\/acs.accounts.6b00329","volume":"49","author":"Kulkarni G.S.","year":"2016","unstructured":"Kulkarni G.S.; Zang W.; Zhong Z.; Nanoelectronic Heterodyne Sensor: A New Electronic Sensing Paradigm. Acc Chem Res 2016,49(11),2578-2586","journal-title":"Acc Chem Res"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.7150\/thno.23856","volume":"8","author":"Draz M.S.","year":"2018","unstructured":"Draz M.S.; Shafiee H.; Applications of gold nanoparticles in virus detection. Theranostics 2018,8(7),1985-2017","journal-title":"Theranostics"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1743-422X-10-201","volume":"10","author":"Carter J.R.","year":"2013","unstructured":"Carter J.R.; Balaraman V.; Kucharski C.A.; Fraser T.S.; Fraser M.J.; A novel dengue virus detection method that couples DNAzyme and gold nanoparticle approaches. Virol J 2013,10,201","journal-title":"Virol J"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"20701","DOI":"10.1073\/pnas.0808988106","volume":"105","author":"Vollmer F.","year":"2008","unstructured":"Vollmer F.; Arnold S.; Keng D.; Single virus detection from the reactive shift of a whispering-gallery mode. Proc Natl Acad Sci USA 2008,105(52),20701-20704","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.tibtech.2015.03.002","volume":"33","author":"Cretich M.","year":"2015","unstructured":"Cretich M.; Daaboul G.G.; Sola L.; \u00dcnl\u00fc M.S.; Chiari M.; Digital detection of biomarkers assisted by nanoparticles: application to diagnostics. Trends Biotechnol 2015,33(6),343-351","journal-title":"Trends Biotechnol"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"40849","DOI":"10.1039\/C7RA07175B","volume":"65","author":"Ahmed S.R.","year":"2017","unstructured":"Ahmed S.R.; Nagy E.; Neethirajan S.; Self-assembled star-shaped chiroplasmonic gold nanoparticles for an ultrasensitive chiro-immunosensor for viruses. RSC Adv 2017,65(7),40849-40857","journal-title":"RSC Adv"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3615707","author":"Lai H.C.","year":"2017","unstructured":"Lai H.C.; Chin S.F.; Pang S.C.; Henry Sum M.S.; Perera D.; Carbon Nanoparticles Based Electrochemical Biosensor Strip for Detection of Japanese Encephalitis Virus. J Nanomater 2017,1-7","journal-title":"J Nanomater"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.bios.2010.01.012","volume":"25","author":"Bai X.","year":"2010","unstructured":"Bai X.; Shao C.; Han X.; Li Y.; Guan Y.; Deng Z.; Visual detection of sub-femtomole DNA by a gold nanoparticle seeded homogeneous reduction assay: toward a generalized sensitivity-enhancing strategy. Biosens Bioelectron 2010,25(8),1984-1988","journal-title":"Biosens Bioelectron"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/diagnostics9030074","volume":"9","author":"Yrad F.M.","year":"2019","unstructured":"Yrad F.M.; Casta\u00f1ares J.M.; Alocilja E.C.; Visual Detection of Dengue-1 RNA Using Gold Nanoparticle-Based Lateral Flow Biosensor. Diagnostics (Basel) 2019,9(3),74","journal-title":"Diagnostics (Basel)"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1021\/nl103210p","volume":"10","author":"Daaboul G.G.","year":"2010","unstructured":"Daaboul G.G.; Yurt A.; Zhang X.; Hwang G.M.; Goldberg B.B.; \u00dcnl\u00fc M.S.; High-throughput detection and sizing of individual low-index nanoparticles and viruses for pathogen identification. Nano Lett 2010,10(11),4727-4731","journal-title":"Nano Lett"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12951-018-0374-x","volume":"16","author":"Hamdy M.E.","year":"2018","unstructured":"Hamdy M.E.; Del Carlo M.; Hussein H.A.; Salah T.A.; El-Deeb A.H.; Emara M.M.; Pezzoni G.; Compagnone D.; Development of gold nanoparticles biosensor for ultrasensitive diagnosis of foot and mouth disease virus. J Nanobiotechnology 2018,16(1),48","journal-title":"J Nanobiotechnology"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jviromet.2016.04.008","volume":"234","author":"Kumvongpin R.","year":"2016","unstructured":"Kumvongpin R.; Jearanaikool P.; Wilailuckana C.; Sae-Ung N.; Prasongdee P.; Daduang S.; Wongsena M.; Boonsiri P.; Kiatpathomchai W.; Swangvaree S.S.; Sandee A.; Daduang J.; High sensitivity, loop-mediated isothermal amplification combined with colorimetric gold-nanoparticle probes for visual detection of high risk human papillomavirus genotypes 16 and 18. J Virol Methods 2016,234,90-95","journal-title":"J Virol Methods"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1039\/C8NR01646A","volume":"10","author":"Draz M.S.","year":"2018","unstructured":"Draz M.S.; Venkataramani M.; Lakshminarayanan H.; Saygili E.; Moazeni M.; Vasan A.; Li Y.; Sun X.; Hua S.; Yu X.G.; Shafiee H.; Nanoparticle-enhanced electrical detection of Zika virus on paper microchips. Nanoscale 2018,10(25),11841-11849","journal-title":"Nanoscale"},{"key":"ref=237","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/187\/1\/012059","volume":"187","author":"Tuan M.A.","year":"2009","unstructured":"Tuan M.A.; Hai N.H.; DNA enrichment by functionalized magnetic nanoparticles for on-site and fast detection of virus in biomedical application. J Phys Conf Ser 2009,187","journal-title":"J Phys Conf Ser"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41428-019-0252-x","volume":"52","author":"Matsubara T.","year":"2020","unstructured":"Matsubara T.; Kubo A.; Sato T.; Detection of influenza virus by agglutination using nanoparticles conjugated with a sialic acid-mimic peptide. Polym J 2020,52,261-266","journal-title":"Polym J"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/wnan.82","volume":"3","author":"Hu Y.","year":"2011","unstructured":"Hu Y.; Fine D.H.; Tasciotti E.; Bouamrani A.; Ferrari M.; Nanodevices in diagnostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011,3(1),11-32","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006889","volume":"12","author":"Koehler J.W.","year":"2018","unstructured":"Koehler J.W.; Douglas C.E.; Minogue T.D.; A highly multiplexed broad pathogen detection assay for infectious disease diagnostics. PLoS Negl Trop Dis 2018,12(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.biotechadv.2016.09.003","volume":"34","author":"Tram D.T.","year":"2016","unstructured":"Tram D.T.; Wang H.; Sugiarto S.; Li T.; Ang W.H.; Lee C.; Pastorin G.; Advances in nanomaterials and their applications in point of care (POC) devices for the diagnosis of infectious diseases. Biotechnol Adv 2016,34(8),1275-1288","journal-title":"Biotechnol Adv"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bios.2018.05.050","volume":"117","author":"Nasseri B.","year":"2018","unstructured":"Nasseri B.; Soleimani N.; Rabiee N.; Kalbasi A.; Karimi M.; Hamblin M.R.; Point-of-care microfluidic devices for pathogen detection. Biosens Bioelectron 2018,117,112-128","journal-title":"Biosens Bioelectron"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/2049936117713593","volume":"4","author":"Singh L.","year":"2017","unstructured":"Singh L.; Kruger H.G.; Maguire G.E.M.; Govender T.; Parboosing R.; The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis 2017,4(4),105-131","journal-title":"Ther Adv Infect Dis"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.biopha.2017.11.026","volume":"97","author":"Prasad M.","year":"2018","unstructured":"Prasad M.; Lambe U.P.; Brar B.; Shah I.; J M.; Ranjan K.; Rao R.; Kumar S.; Mahant S.; Khurana S.K.; Iqbal H.M.N.; Dhama K.; Misri J.; Prasad G.; Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed Pharmacother 2018,97,1521-1537","journal-title":"Biomed Pharmacother"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"14051","DOI":"10.3390\/molecules200814051","volume":"20","author":"Szunerits S.","year":"2015","unstructured":"Szunerits S.; Barras A.; Khanal M.; Pagneux Q.; Boukherroub R.; Nanostructures for the Inhibition of Viral Infections. Molecules 2015,20(8),14051-14081","journal-title":"Molecules"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"155","DOI":"10.13005\/bbra\/1246","volume":"11","author":"Devi C.S.","year":"2013","unstructured":"Devi C.S.; Modi M.A.; Unnikrishnan U.; Mohanasrinivasan V.; A review on Chikungunya and suggesting a hypothesis of nano-based drug delivery. Biosci Biotechnol Res Asia 2013,11(1),155-158","journal-title":"Biosci Biotechnol Res Asia"},{"key":"ref=247","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001997","volume":"13","author":"Dunning J.","year":"2016","unstructured":"Dunning J.; Sahr F.; Rojek A.; Gannon F.; Carson G.; Idriss B.; Massaquoi T.; Gandi R.; Joseph S.; Osman H.K.; Brooks T.J.; Simpson A.J.; Goodfellow I.; Thorne L.; Arias A.; Merson L.; Castle L.; Howell-Jones R.; Pardinaz-Solis R.; Hope-Gill B.; Ferri M.; Grove J.; Kowalski M.; Stepniewska K.; Lang T.; Whitehead J.; Olliaro P.; Samai M.; Horby P.W.; Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial. PLoS Med 2016,13(4)","journal-title":"PLoS Med"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijid.2016.02.611","volume":"45","author":"Chowdhury P.","year":"2016","unstructured":"Chowdhury P.; Bora T.; Khan S.A.; Chakraborty B.; Senapati K.; Sengupta M.; Borchetia S.; Bandyopadhyay T.; Inhibition of Japanese encephalitis virus infection by biogenic catechin silver nanoparticles: An in vitro study. Int J Infect Dis 2016,45(S1),276","journal-title":"Int J Infect Dis"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"13990","DOI":"10.1038\/s41598-018-32033-w","volume":"8","author":"LaBauve A.E.","year":"2018","unstructured":"LaBauve A.E.; Rinker T.E.; Noureddine A.; Serda R.E.; Howe J.Y.; Sherman M.B.; Rasley A.; Brinker C.J.; Sasaki D.Y.; Negrete O.A.; Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection. Sci Rep 2018,8(1),13990","journal-title":"Sci Rep"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1039\/C6NR07315H","volume":"9","author":"Karimi M.","year":"2017","unstructured":"Karimi M.; Zangabad P.S.; Mehdizadeh F.; Malekzad H.; Ghasemi A.; Bahrami S.; Zare H.; Moghoofei M.; Hekmatmanesh A.; Hamblin M.R.; Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale 2017,9(4),1356-1392","journal-title":"Nanoscale"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1073\/pnas.0914561107","volume":"107","author":"Chakravarthy K.V.","year":"2010","unstructured":"Chakravarthy K.V.; Bonoiu A.C.; Davis W.G.; Ranjan P.; Ding H.; Hu R.; Bowzard J.B.; Bergey E.J.; Katz J.M.; Knight P.R.; Sambhara S.; Prasad P.N.; Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc Natl Acad Sci USA 2010,107(22),10172-10177","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/2468187306666161009221159","volume":"7","author":"Sironmani T.A.","year":"2017","unstructured":"Sironmani T.A.; Immuno - Functionalized Silver Nanoparticles for Diagnostics, Therapeutics and Protection of Rabies Viral Infection. Curr Nanomed 2017,7(1),73-82","journal-title":"Curr Nanomed"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature14442","volume":"521","author":"Thi E.P.","year":"2015","unstructured":"Thi E.P.; Mire C.E.; Lee A.C.; Geisbert J.B.; Zhou J.Z.; Agans K.N.; Snead N.M.; Deer D.J.; Barnard T.R.; Fenton K.A.; MacLachlan I.; Geisbert T.W.; Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature 2015,521(7552),362-365","journal-title":"Nature"},{"key":"ref=254","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118345","volume":"10","author":"Ayithan N.","year":"2015","unstructured":"Ayithan N.; Bradfute S.B.; Anthony S.M.; Stuthman K.S.; Bavari S.; Bray M.; Ozato K.; Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection. PLoS One 2015,10(2)","journal-title":"PLoS One"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nmat5053","volume":"17","author":"Cagno V.","year":"2018","unstructured":"Cagno V.; Andreozzi P.; D\u2019Alicarnasso M.; Jacob Silva P.; Mueller M.; Galloux M.; Le Goffic R.; Jones S.T.; Vallino M.; Hodek J.; Weber J.; Sen S.; Jane\u010dek E.R.; Bekdemir A.; Sanavio B.; Martinelli C.; Donalisio M.; Rameix Welti M.A.; Eleouet J.F.; Han Y.; Kaiser L.; Vukovic L.; Tapparel C.; Kr\u00e1l P.; Krol S.; Lembo D.; Stellacci F.; Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater 2018,17(2),195-203","journal-title":"Nat Mater"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/molecules22081370","volume":"22","author":"Aderibigbe B.A.","year":"2017","unstructured":"Aderibigbe B.A.; Metal-Based Nanoparticles for the Treatment of Infectious Diseases. Molecules 2017,22(8),1370","journal-title":"Molecules"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1109\/TNB.2015.2508718","volume":"15","author":"Rafiei S.","year":"2016","unstructured":"Rafiei S.; Rezatofighi S.E.; Roayaei Ardakani M.; Rastegarzadeh S.; Gold Nanoparticles Impair Foot-and-Mouth Disease Virus Replication. IEEE Trans Nanobioscience 2016,15(1),34-40","journal-title":"IEEE Trans Nanobioscience"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.nano.2016.01.021","volume":"12","author":"Borrego B.","year":"2016","unstructured":"Borrego B.; Lorenzo G.; Mota-Morales J.D.; Almanza-Reyes H.; Mateos F.; L\u00f3pez-Gil E.; de la Losa N.; Burmistrov V.A.; Pestryakov A.N.; Brun A.; Bogdanchikova N.; Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo. Nanomedicine (Lond) 2016,12(5),1185-1192","journal-title":"Nanomedicine (Lond)"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/13590840310001594061","volume":"13","author":"Do Comm Cnmo E.R.","year":"2003","unstructured":"Do Comm Cnmo E.R.; Viral Pathogens and Severe Acute Respiratory Syndrome: Oligodynamic Ag+ for Direct Immune Intervention. J Nutr Environ Med 2003,13(2),109-118","journal-title":"J Nutr Environ Med"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"Lucky S.S.","year":"2015","unstructured":"Lucky S.S.; Soo K.C.; Zhang Y.; Nanoparticles in photodynamic therapy. Chem Rev 2015,115(4),1990-2042","journal-title":"Chem Rev"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"9494","DOI":"10.1039\/C4NR00708E","volume":"6","author":"Jaque D.","year":"2014","unstructured":"Jaque D.; Mart\u00ednez Maestro L.; del Rosal B.; Haro-Gonzalez P.; Benayas A.; Plaza J.L.; Mart\u00edn Rodr\u00edguez E.; Garc\u00eda Sol\u00e9 J.; Nanoparticles for photothermal therapies. Nanoscale 2014,6(16),9494-9530","journal-title":"Nanoscale"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jmmm.2013.11.006","volume":"354","author":"Deatsch A.E.","year":"2014","unstructured":"Deatsch A.E.; Evans B.A.; Heating efficiency in magnetic nanoparticle hyperthermia. J Magn Magn Mater 2014,354,163-172","journal-title":"J Magn Magn Mater"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","volume":"8","author":"Chakraborty C.","year":"2017","unstructured":"Chakraborty C.; Sharma A.R.; Sharma G.; Doss C.G.P.; Lee S.S.; Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine. Mol Ther Nucleic Acids 2017,8,132-143","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.2147\/IJN.S46900","volume":"9","author":"Weissig V.","year":"2014","unstructured":"Weissig V.; Pettinger T.K.; Murdock N.; Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine 2014,9,4357-4373","journal-title":"Int J Nanomedicine"},{"key":"ref=265","year":"2012","unstructured":"Alnylam Pharmaceuticals. Complete Results of our ALN-RSV01 Phase IIb Study Available from:(Accessed on 25th November, 2018).2012"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nm1174","volume":"11","author":"Zhang W.","year":"2005","unstructured":"Zhang W.; Yang H.; Kong X.; Mohapatra S.; San Juan-Vergara H.; Hellermann G.; Behera S.; Singam R.; Lockey R.F.; Mohapatra S.S.; Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 2005,11(1),56-62","journal-title":"Nat Med"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3762\/bjnano.10.104","volume":"10","author":"Alghrair Z.K.","year":"2019","unstructured":"Alghrair Z.K.; Fernig D.G.; Ebrahimi B.; Enhanced inhibition of influenza virus infection by peptide-noble-metal nanoparticle conjugates. Beilstein J Nanotechnol 2019,10,1038-1047","journal-title":"Beilstein J Nanotechnol"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"Bobo D.","year":"2016","unstructured":"Bobo D.; Robinson K.J.; Islam J.; Thurecht K.J.; Corrie S.R.; Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. Pharm Res 2016,33(10),2373-2387","journal-title":"Pharm Res"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"Kanekiyo M.","year":"2013","unstructured":"Kanekiyo M.; Wei C.J.; Yassine H.M.; McTamney P.M.; Boyington J.C.; Whittle J.R.; Rao S.S.; Kong W.P.; Wang L.; Nabel G.J.; Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 2013,499(7456),102-106","journal-title":"Nature"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","volume":"9","author":"Deng L.","year":"2018","unstructured":"Deng L.; Mohan T.; Chang T.Z.; Gonzalez G.X.; Wang Y.; Kwon Y.M.; Kang S.M.; Compans R.W.; Champion J.A.; Wang B.Z.; Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nat Commun 2018,9(1),359","journal-title":"Nat Commun"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","volume":"10","author":"Al-Halifa S.","year":"2019","unstructured":"Al-Halifa S.; Gauthier L.; Arpin D.; Bourgault S.; Archambault D.; Nanoparticle-based vaccines against respiratory viruses. Front Immunol 2019,10,22","journal-title":"Front Immunol"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1016\/j.vaccine.2014.08.003","volume":"32","author":"van de Sandt C.E.","year":"2014","unstructured":"van de Sandt C.E.; Kreijtz J.H.; Geelhoed-Mieras M.M.; Vogelzang-van Trierum S.E.; Nieuwkoop N.J.; van de Vijver D.A.; Fouchier R.A.; Osterhaus A.D.; Morein B.; Rimmelzwaan G.F.; Novel G3\/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine. Vaccine 2014,32(43),5614-5623","journal-title":"Vaccine"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1016\/j.vaccine.2010.04.011","volume":"28","author":"Even-Or O.","year":"2010","unstructured":"Even-Or O.; Samira S.; Rochlin E.; Balasingam S.; Mann A.J.; Lambkin-Williams R.; Spira J.; Goldwaser I.; Ellis R.; Barenholz Y.; Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine. Vaccine 2010,28(39),6527-6541","journal-title":"Vaccine"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1016\/j.vaccine.2009.04.054","volume":"27","author":"Lay M.","year":"2009","unstructured":"Lay M.; Callejo B.; Chang S.; Hong D.K.; Lewis D.B.; Carroll T.D.; Matzinger S.; Fritts L.; Miller C.J.; Warner J.F.; Liang L.; Fairman J.; Cationic lipid\/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection. Vaccine 2009,27(29),3811-3820","journal-title":"Vaccine"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1517\/17425247.2010.538047","volume":"7","author":"Sullivan S.M.","year":"2010","unstructured":"Sullivan S.M.; Doukas J.; Hartikka J.; Smith L.; Rolland A.; Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines. Expert Opin Drug Deliv 2010,7(12),1433-1446","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.vaccine.2016.02.033","volume":"34","author":"Bengtsson K.L.","year":"2016","unstructured":"Bengtsson K.L.; Song H.; Stertman L.; Liu Y.; Flyer D.C.; Massare M.J.; Xu R.H.; Zhou B.; Lu H.; Kwilas S.A.; Hahn T.J.; Kpamegan E.; Hooper J.; Carrion R.; Glenn G.; Smith G.; Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola\/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine 2016,34(16),1927-1935","journal-title":"Vaccine"},{"key":"ref=277","author":"Vaxinano S.E.","year":"2017","unstructured":"Vaxinano S.E.; Vaxinano specializes in the development of prophylactic and therapeutic vaccines for infectious diseases, for human and animal health markets Available from: (Accessed on 25th November, 2018).2017"},{"key":"ref=278","year":"2017","unstructured":"Emergex Vaccines. Impact report Available from: (Accessed on 25th November, 2018).2017"},{"key":"ref=279","year":"2016","unstructured":"CaPtivate Pharmaceuticals. Calcium phosphate nanoparticle vaccine adjuvant Available from: (Accessed on 26th November, 2018).2016"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2018.00790","volume":"9","author":"Hua S.","year":"2018","unstructured":"Hua S.; de Matos M.B.C.; Metselaar J.M.; Storm G.; Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization. Front Pharmacol 2018,9,790","journal-title":"Front Pharmacol"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","volume":"15","author":"Paliwal R.","year":"2014","unstructured":"Paliwal R.; Babu R.J.; Palakurthi S.; Nanomedicine scale-up technologies: feasibilities and challenges. AAPS PharmSciTech 2014,15(6),1527-1534","journal-title":"AAPS PharmSciTech"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","volume":"108","author":"Hare J.I.","year":"2017","unstructured":"Hare J.I.; Lammers T.; Ashford M.B.; Puri S.; Storm G.; Barry S.T.; Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Adv Drug Deliv Rev 2017,108,25-38","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/B978-0-323-50878-0.00022-7","author":"Pita R.","year":"2018","unstructured":"Pita R.; Ehmann F.; Th\u00fcrmer R.; Regulation of Biomedical Applications of Functionalized Nanomaterials in the European Union Micro and Nano Technologies 2018,653-679","journal-title":"Micro and Nano Technologies"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"19547","DOI":"10.1039\/C8NR05948A","volume":"10","author":"Babych M.","year":"2018","unstructured":"Babych M.; Bertheau-Mailhot G.; Zottig X.; Dion J.; Gauthier L.; Archambault D.; Bourgault S.; Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus. Nanoscale 2018,10(41),19547-19556","journal-title":"Nanoscale"},{"key":"ref=285","first-page":"30556","volume":"18","author":"Bazzill J.D.","year":"2018","unstructured":"Bazzill J.D.; Stronsky S.M.; Kalinyak L.C.; Ochyl L.J.; Steffens J.T.; van Tongeren S.A.; Cooper C.L.; Moon J.J.; Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine 2018,18,30556-30562","journal-title":"Nanomedicine"},{"key":"ref=286","first-page":"509","volume":"56","author":"Kraaijeveld C.A.","year":"1984","unstructured":"Kraaijeveld C.A.; Schilham M.; Jansen J.; Benaissa-Trouw B.; Harmsen M.; van Houte A.J.; Snippe H.; The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses. Clin Exp Immunol 1984,56(3),509-514","journal-title":"Clin Exp Immunol"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1016\/j.vaccine.2008.03.025","volume":"26","author":"Greenwood D.L.","year":"2008","unstructured":"Greenwood D.L.; Dynon K.; Kalkanidis M.; Xiang S.; Plebanski M.; Scheerlinck J.P.; Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads. Vaccine 2008,26(22),2706-2713","journal-title":"Vaccine"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1128\/JVI.03118-13","volume":"88","author":"Acu\u00f1a R.","year":"2014","unstructured":"Acu\u00f1a R.; Cifuentes-Mu\u00f1oz N.; M\u00e1rquez C.L.; Bulling M.; Klingstr\u00f6m J.; Mancini R.; Lozach P.Y.; Tischler N.D.; Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles. J Virol 2014,88(4),2344-2348","journal-title":"J Virol"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.provac.2010.03.008","volume":"2","author":"Shan S.","year":"2010","unstructured":"Shan S.; Poinern E.; Ellis T.; Fenwick S.; Le X.; Edwards J.; Jiang Z.T.; Development of a Nano-vaccine against a Wild Bird H6N2 Avian Influenza Virus. Procedia Vaccinol 2010,2(1),40-43","journal-title":"Procedia Vaccinol"},{"key":"ref=290","doi-asserted-by":"publisher","DOI":"10.4172\/2324-8955.1000179","volume":"7","author":"Li J.","year":"2018","unstructured":"Li J.; Helal Z.; Ladman B.; Karch C.; Gelb J.; Burkhard P.; Khan M.I.; Nanoparticle Vaccine for Avian Influenza Virus: A Challenge Study against Highly Pathogenic H5N2 Subtype. J Virol Antivir Res 2018,7(1)","journal-title":"J Virol Antivir Res"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.vaccine.2007.11.067","volume":"26","author":"Okamoto S.","year":"2008","unstructured":"Okamoto S.; Yoshii H.; Ishikawa T.; Akagi T.; Akashi M.; Takahashi M.; Yamanishi K.; Mori Y.; Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine 2008,26(5),589-594","journal-title":"Vaccine"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","volume":"77","author":"Kojima A.","year":"2003","unstructured":"Kojima A.; Yasuda A.; Asanuma H.; Ishikawa T.; Takamizawa A.; Yasui K.; Kurata T.; Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine. J Virol 2003,77(16),8745-8755","journal-title":"J Virol"},{"key":"ref=293","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004081","volume":"9","author":"de Wispelaere M.","year":"2015","unstructured":"de Wispelaere M.; Ricklin M.; Souque P.; Frenkiel M.P.; Paulous S.; Garc\u00eca-Nicol\u00e0s O.; Summerfield A.; Charneau P.; Despr\u00e8s P.; A Lentiviral vector expressing japanese encephalitis virus-like particles elicits broad neutralizing antibody response in pigs. PLoS Negl Trop Dis 2015,9(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","volume":"185","author":"Demento S.L.","year":"2010","unstructured":"Demento S.L.; Bonaf\u00e9 N.; Cui W.; Kaech S.M.; Caplan M.J.; Fikrig E.; Ledizet M.; Fahmy T.M.; TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol 2010,185(5),2989-2997","journal-title":"J Immunol"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/mmr.2015.3419","volume":"12","author":"Zhai Y.","year":"2015","unstructured":"Zhai Y.; Zhou Y.; Li X.; Feng G.; Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB\/c mouse granulocyte-macrophage colony-stimulating factor. Mol Med Rep 2015,12(1),199-209","journal-title":"Mol Med Rep"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1743-422X-7-146","volume":"7","author":"Spohn G.","year":"2010","unstructured":"Spohn G.; Jennings G.T.; Martina B.E.; Keller I.; Beck M.; Pumpens P.; Osterhaus A.D.; Bachmann M.F.; A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Virol J 2010,7,146","journal-title":"Virol J"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/smll.201000331","volume":"6","author":"Prow T.W.","year":"2010","unstructured":"Prow T.W.; Chen X.; Prow N.A.; Fernando G.J.; Tan C.S.; Raphael A.P.; Chang D.; Ruutu M.P.; Jenkins D.W.; Pyke A.; Crichton M.L.; Raphaelli K.; Goh L.Y.; Frazer I.H.; Roberts M.S.; Gardner J.; Khromykh A.A.; Suhrbier A.; Hall R.A.; Kendall M.A.; Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small 2010,6(16),1776-1784","journal-title":"Small"},{"key":"ref=298","unstructured":"Lawrence Livermore National Laboratory. Nanolipoprotein Particles for Vaccine and Adjuvant Delivery Available from: (Accessed on 23rd November, 2018)."},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1021\/nn3057005","volume":"7","author":"Niikura K.","year":"2013","unstructured":"Niikura K.; Matsunaga T.; Suzuki T.; Kobayashi S.; Yamaguchi H.; Orba Y.; Kawaguchi A.; Hasegawa H.; Kajino K.; Ninomiya T.; Ijiro K.; Sawa H.; Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano 2013,7(5),3926-3938","journal-title":"ACS Nano"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1021\/bc100083d","volume":"21","author":"Fischer N.O.","year":"2010","unstructured":"Fischer N.O.; Infante E.; Ishikawa T.; Blanchette C.D.; Bourne N.; Hoeprich P.D.; Mason P.W.; Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis. Bioconjug Chem 2010,21(6),1018-1022","journal-title":"Bioconjug Chem"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.reffit.2016.10.007","volume":"2","author":"Nivedh K.","year":"2016","unstructured":"Nivedh K.; Namasivayam S.K.R.; Nishanth A.N.; Effect of functionalization of polymeric nanoparticles incorporated with whole attenuated rabies virus antigen on sustained release and efficacy. Resource-Efficient Technologies 2016,2,S25-S38","journal-title":"Resource-Efficient Technologies"},{"key":"ref=302","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18869\/acadpub.vacres.1.1.31","volume":"1","author":"Asgary V.","year":"2014","unstructured":"Asgary V.; Mafi O. K.; Khosravy M. S.; Janani A.; Asl N. N.; Bashar R.; Poortaghi H.; Cohan H. A.; Shoari A.; Cohan R. A.; Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus. vacres 2014,1(1),31-34","journal-title":"vacres"},{"key":"ref=303","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019848","volume":"6","author":"Liu X.","year":"2011","unstructured":"Liu X.; Lin H.; Tang Q.; Li C.; Yang S.; Wang Z.; Wang C.; He Q.; Cao B.; Feng Z.; Guan X.; Zhu J.; Characterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine. PLoS One 2011,6(5)","journal-title":"PLoS One"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.2147\/IJN.S109098","volume":"11","author":"Asgary V.","year":"2016","unstructured":"Asgary V.; Shoari A.; Baghbani-Arani F.; Sadat Shandiz S.A.; Khosravy M.S.; Janani A.; Bigdeli R.; Bashar R.; Cohan R.A.; Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine. Int J Nanomedicine 2016,11,3597-3605","journal-title":"Int J Nanomedicine"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","volume":"2","author":"Lutz J.","year":"2017","unstructured":"Lutz J.; Lazzaro S.; Habbeddine M.; Schmidt K.E.; Baumhof P.; Mui B.L.; Tam Y.K.; Madden T.D.; Hope M.J.; Heidenreich R.; Fotin-Mleczek M.; Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. NPJ Vaccines 2017,2,29","journal-title":"NPJ Vaccines"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/vim.2017.0024","volume":"31","author":"Asgary V.","year":"2018","unstructured":"Asgary V.; Shoari A.; Afshar Moayad M.; Shafiee Ardestani M.; Bigdeli R.; Ghazizadeh L.; Khosravy M.S.; Panahnejad E.; Janani A.; Bashar R.; Abedi M.; Ahangari Cohan R.; Evaluation of G2 citric acid-based dendrimer as an adjuvant in veterinary rabies vaccine. Viral Immunol 2018,31(1),47-54","journal-title":"Viral Immunol"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijpharm.2018.05.018","volume":"545","author":"Bansal A.","year":"2018","unstructured":"Bansal A.; Wu X.; Olson V.; D\u2019Souza M.J.; Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel. Int J Pharm 2018,545(1-2),318-328","journal-title":"Int J Pharm"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","volume":"73","author":"Pimentel T.A.P.F.","year":"2009","unstructured":"Pimentel T.A.P.F.; Yan Z.; Jeffers S.A.; Holmes K.V.; Hodges R.S.; Burkhard P.; Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine. Chem Biol Drug Des 2009,73(1),53-61","journal-title":"Chem Biol Drug Des"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","volume":"32","author":"Coleman C.M.","year":"2014","unstructured":"Coleman C.M.; Liu Y.V.; Mu H.; Taylor J.K.; Massare M.; Flyer D.C.; Smith G.E.; Frieman M.B.; Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine 2014,32(26),3169-3174","journal-title":"Vaccine"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","volume":"29","author":"Liu Y.V.","year":"2011","unstructured":"Liu Y.V.; Massare M.J.; Barnard D.L.; Kort T.; Nathan M.; Wang L.; Smith G.; Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Vaccine 2011,29(38),6606-6613","journal-title":"Vaccine"},{"key":"ref=311","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035421","volume":"7","author":"Tseng C.T.","year":"2012","unstructured":"Tseng C.T.; Sbrana E.; Iwata-Yoshikawa N.; Newman P.C.; Garron T.; Atmar R.L.; Peters C.J.; Couch R.B.; Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One 2012,7(4)","journal-title":"PLoS One"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2172-11-65","volume":"11","author":"Shim B.S.","year":"2010","unstructured":"Shim B.S.; Park S.M.; Quan J.S.; Jere D.; Chu H.; Song M.K.; Kim D.W.; Jang Y.S.; Yang M.S.; Han S.H.; Park Y.H.; Cho C.S.; Yun C.H.; Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus\/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses. BMC Immunol 2010,11,65","journal-title":"BMC Immunol"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.febslet.2004.09.009","volume":"576","author":"Mortola E.","year":"2004","unstructured":"Mortola E.; Roy P.; Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett 2004,576(1-2),174-178","journal-title":"FEBS Lett"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.18632\/oncotarget.8475","volume":"8","author":"Wang C.","year":"2017","unstructured":"Wang C.; Zheng X.; Gai W.; Zhao Y.; Wang H.; Wang H.; Feng N.; Chi H.; Qiu B.; Li N.; Wang T.; Gao Y.; Yang S.; Xia X.; MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques. Oncotarget 2017,8(8),12686-12694","journal-title":"Oncotarget"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.vaccine.2017.02.012","volume":"35","author":"Coleman C.M.","year":"2017","unstructured":"Coleman C.M.; Venkataraman T.; Liu Y.V.; Glenn G.M.; Smith G.E.; Flyer D.C.; Frieman M.B.; MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine 2017,35(12),1586-1589","journal-title":"Vaccine"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fimmu.2018.01093","volume":"9","author":"Kim Y.S.","year":"2018","unstructured":"Kim Y.S.; Son A.; Kim J.; Kwon S.B.; Kim M.H.; Kim P.; Kim J.; Byun Y.H.; Sung J.; Lee J.; Yu J.E.; Park C.; Kim Y.S.; Cho N.H.; Chang J.; Seong B.L.; Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles. Front Immunol 2018,9,1093","journal-title":"Front Immunol"},{"key":"ref=317","first-page":"529","volume":"4","author":"Soliman M.G.","year":"2017","unstructured":"Soliman M.G.; Mohamed A.F.; El Sayed R.A.; Elqasem A.A.A.; Immunohistochemical and histological changes in the spleen induced by gold nanoparticles as alternative adjuvant against rift vally fever virus. European J Biomed Pharma Sci 2017,4,529","journal-title":"European J Biomed Pharma Sci"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4172\/2157-7560.1000115","volume":"2","author":"Abd el-Razek N.E.E.","year":"2011","unstructured":"Abd el-Razek N.E.E.; Shoman S.A.; Mohamed A.F.; Nanocapsulated rift valley fever vaccine candidates and relative immunological and histopathological reactivity in out bred swiss mice. J Vaccines Vaccin 2011,2(1),115","journal-title":"J Vaccines Vaccin"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","volume":"385","author":"N\u00e4slund J.","year":"2009","unstructured":"N\u00e4slund J.; Lagerqvist N.; Habjan M.; Lundkvist A.; Evander M.; Ahlm C.; Weber F.; Bucht G.; Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. Virology 2009,385(2),409-415","journal-title":"Virology"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","volume":"397","author":"Mandell R.B.","year":"2010","unstructured":"Mandell R.B.; Koukuntla R.; Mogler L.J.; Carzoli A.K.; Freiberg A.N.; Holbrook M.R.; Martin B.K.; Staplin W.R.; Vahanian N.N.; Link C.J.; Flick R.; A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge. Virology 2010,397(1),187-198","journal-title":"Virology"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","volume":"198","author":"Pepini T.","year":"2017","unstructured":"Pepini T.; Pulichino A.M.; Carsillo T.; Carlson A.L.; Sari-Sarraf F.; Ramsauer K.; Debasitis J.C.; Maruggi G.; Otten G.R.; Geall A.J.; Yu D.; Ulmer J.B.; Iavarone C.; Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design. J Immunol 2017,198(10),4012-4024","journal-title":"J Immunol"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"11087","DOI":"10.1021\/acsnano.9b03660","volume":"13","author":"Fan Y.","year":"2019","unstructured":"Fan Y.; Stronsky S.M.; Xu Y.; Steffens J.T.; van Tongeren S.A.; Erwin A.; Cooper C.L.; Moon J.J.; Multilamellar vaccine particle elicits potent immune activation with protein antigens and protects mice against ebola virus infection. ACS Nano 2019,13(10),11087-11096","journal-title":"ACS Nano"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1038\/s41598-018-29135-w","volume":"8","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Ye L.; Lin F.; Gomaa Y.; Flyer D.; Carrion R.; Patterson J.L.; Prausnitz M.R.; Smith G.; Glenn G.; Wu H.; Compans R.W.; Yang C.; Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge. Sci Rep 2018,8(1),11193","journal-title":"Sci Rep"},{"key":"ref=324","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201600750","volume":"6","author":"Yang H.W.","year":"2017","unstructured":"Yang H.W.; Ye L.; Guo X.D.; Yang C.; Compans R.W.; Prausnitz M.R.; Ebola vaccination using a DNA vaccine coated on PLGA-PLL\/\u03b3PGA nanoparticles administered using a microneedle patch. Adv Healthc Mater 2017,6(1)","journal-title":"Adv Healthc Mater"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","volume":"113","author":"Chahal J.S.","year":"2016","unstructured":"Chahal J.S.; Khan O.F.; Cooper C.L.; McPartlan J.S.; Tsosie J.K.; Tilley L.D.; Sidik S.M.; Lourido S.; Langer R.; Bavari S.; Ploegh H.L.; Anderson D.G.; Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci USA 2016,113(29),E4133-E4142","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"S1053","DOI":"10.1093\/infdis\/jir346","volume":"204","author":"Warfield K.L.","year":"2011","unstructured":"Warfield K.L.; Aman M.J.; Advances in virus-like particle vaccines for filoviruses. J Infect Dis 2011,204(Suppl. 3),S1053-S1059","journal-title":"J Infect Dis"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"15889","DOI":"10.1073\/pnas.2237038100","volume":"100","author":"Warfield K.L.","year":"2003","unstructured":"Warfield K.L.; Bosio C.M.; Welcher B.C.; Deal E.M.; Mohamadzadeh M.; Schmaljohn A.; Aman M.J.; Bavari S.; Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci USA 2003,100(26),15889-15894","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"S430","DOI":"10.1086\/520583","volume":"196","author":"Warfield K.L.","year":"2007","unstructured":"Warfield K.L.; Swenson D.L.; Olinger G.G.; Kalina W.V.; Aman M.J.; Bavari S.; Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J Infect Dis 2007,196(Suppl. 2),S430-S437","journal-title":"J Infect Dis"},{"key":"ref=329","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089735","volume":"9","author":"Martins K.A.","year":"2014","unstructured":"Martins K.A.; Steffens J.T.; van Tongeren S.A.; Wells J.B.; Bergeron A.A.; Dickson S.P.; Dye J.M.; Salazar A.M.; Bavari S.; Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS One 2014,9(2)","journal-title":"PLoS One"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/vim.2014.0071","volume":"28","author":"Martins K.","year":"2015","unstructured":"Martins K.; Carra J.H.; Cooper C.L.; Kwilas S.A.; Robinson C.G.; Shurtleff A.C.; Schokman R.D.; Kuehl K.A.; Wells J.B.; Steffens J.T.; van Tongeren S.A.; Hooper J.W.; Bavari S.; Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein. Viral Immunol 2015,28(1),62-70","journal-title":"Viral Immunol"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1016\/S0264-410X(99)00170-X","volume":"17","author":"Rao M.","year":"1999","unstructured":"Rao M.; Matyas G.R.; Grieder F.; Anderson K.; Jahrling P.B.; Alving C.R.; Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A. Vaccine 1999,17(23-24),2991-2998","journal-title":"Vaccine"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","volume":"76","author":"Rao M.","year":"2002","unstructured":"Rao M.; Bray M.; Alving C.R.; Jahrling P.; Matyas G.R.; Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells. J Virol 2002,76(18),9176-9185","journal-title":"J Virol"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12967-015-0593-y","volume":"13","author":"Carra J.H.","year":"2015","unstructured":"Carra J.H.; Martins K.A.O.; Schokman R.D.; Robinson C.G.; Steffens J.T.; Bavari S.; A thermostable, chromatographically purified Ebola nano-VLP vaccine. J Transl Med 2015,13,228","journal-title":"J Transl Med"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"S421","DOI":"10.1086\/520612","volume":"196","author":"Warfield K.L.","year":"2007","unstructured":"Warfield K.L.; Posten N.A.; Swenson D.L.; Olinger G.G.; Esposito D.; Gillette W.K.; Hopkins R.F.; Costantino J.; Panchal R.G.; Hartley J.L.; Aman M.J.; Bavari S.; Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents. J Infect Dis 2007,196(Suppl. 2),S421-S429","journal-title":"J Infect Dis"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41541-017-0023-7","volume":"2","author":"Walpita P.","year":"2017","unstructured":"Walpita P.; Cong Y.; Jahrling P.B.; Rojas O.; Postnikova E.; Yu S.; Johns L.; Holbrook M.R.; A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. NPJ Vaccines 2017,2,21","journal-title":"NPJ Vaccines"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jprot.2017.10.012","volume":"172","author":"Vera-Velasco N.M.","year":"2018","unstructured":"Vera-Velasco N.M.; Garc\u00eda-Murria M.J.; S\u00e1nchez Del Pino M.M.; Mingarro I.; Martinez-Gil L.; Proteomic composition of Nipah virus-like particles. J Proteomics 2018,172,190-200","journal-title":"J Proteomics"},{"key":"ref=337","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018437","volume":"6","author":"Walpita P.","year":"2011","unstructured":"Walpita P.; Barr J.; Sherman M.; Basler C.F.; Wang L.; Vaccine potential of Nipah virus-like particles. PLoS One 2011,6(4)","journal-title":"PLoS One"},{"key":"ref=338","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005071","volume":"10","author":"Metz S.W.","year":"2016","unstructured":"Metz S.W.; Tian S.; Hoekstra G.; Yi X.; Stone M.; Horvath K.; Miley M.J.; DeSimone J.; Luft C.J.; de Silva A.M.; Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses. PLoS Negl Trop Dis 2016,10(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=339","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006793","volume":"12","author":"Metz S.W.","year":"2018","unstructured":"Metz S.W.; Thomas A.; Brackbill A.; Xianwen Y.; Stone M.; Horvath K.; Miley M.J.; Luft C.; DeSimone J.M.; Tian S.; de Silva A.M.; Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype. PLoS Negl Trop Dis 2018,12(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"34215","DOI":"10.1038\/srep34215","volume":"6","author":"Swaminathan G.","year":"2016","unstructured":"Swaminathan G.; Thoryk E.A.; Cox K.S.; Smith J.S.; Wolf J.J.; Gindy M.E.; Casimiro D.R.; Bett A.J.; A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep 2016,6,34215","journal-title":"Sci Rep"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/1743-422X-8-333","volume":"8","author":"Zhang S.","year":"2011","unstructured":"Zhang S.; Liang M.; Gu W.; Li C.; Miao F.; Wang X.; Jin C.; Zhang L.; Zhang F.; Zhang Q.; Jiang L.; Li M.; Li D.; Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice. Virol J 2011,8,333","journal-title":"Virol J"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12866-014-0233-3","volume":"14","author":"Liu Y.","year":"2014","unstructured":"Liu Y.; Zhou J.; Yu Z.; Fang D.; Fu C.; Zhu X.; He Z.; Yan H.; Jiang L.; Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties. BMC Microbiol 2014,14,233","journal-title":"BMC Microbiol"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41598-017-00193-w","volume":"7","author":"Chahal J.S.","year":"2017","unstructured":"Chahal J.S.; Fang T.; Woodham A.W.; Khan O.F.; Ling J.; Anderson D.G.; Ploegh H.L.; An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model. Sci Rep 2017,7(1),252","journal-title":"Sci Rep"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"e00834","DOI":"10.1128\/JVI.00834-17","volume":"91","author":"Garg H.","year":"2017","unstructured":"Garg H.; Sedano M.; Plata G.; Punke E.B.; Joshi A.; Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. J Virol 2017,91(20),e00834-e17","journal-title":"J Virol"},{"key":"ref=345","first-page":"P1114","volume":"168","author":"Richner J. M.","year":"2017","unstructured":"Richner J. M.; Himansu S.; Dowd K. A.; Butler S. L.; Salazar V.; Fox J. M.; Julander J. G.; Tang W. W.; Shresta S.; Pierson T. C.; Ciaramella G.; Diamond M S.; Modified mRNA Vaccines Protect against Zika Virus Infection 2017,168(6),P1114-P1125","journal-title":"Modified mRNA Vaccines Protect against Zika Virus Infection"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","volume":"169","author":"Richner J.M.","year":"2017","unstructured":"Richner J.M.; Himansu S.; Dowd K.A.; Butler S.L.; Salazar V.; Fox J.M.; Julander J.G.; Tang W.W.; Shresta S.; Pierson T.C.; Ciaramella G.; Diamond M.S.; Modified mRNA Vaccines Protect against Zika Virus Infection. Cell 2017,169(1),176","journal-title":"Cell"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"Pardi N.","year":"2017","unstructured":"Pardi N.; Hogan M.J.; Pelc R.S.; Muramatsu H.; Andersen H.; DeMaso C.R.; Dowd K.A.; Sutherland L.L.; Scearce R.M.; Parks R.; Wagner W.; Granados A.; Greenhouse J.; Walker M.; Willis E.; Yu J.S.; McGee C.E.; Sempowski G.D.; Mui B.L.; Tam Y.K.; Huang Y.J.; Vanlandingham D.; Holmes V.M.; Balachandran H.; Sahu S.; Lifton M.; Higgs S.; Hensley S.E.; Madden T.D.; Hope M.J.; Karik\u00f3 K.; Santra S.; Graham B.S.; Lewis M.G.; Pierson T.C.; Haynes B.F.; Weissman D.; Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 2017,543(7644),248-251","journal-title":"Nature"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","volume":"170","author":"Richner J.M.","year":"2017","unstructured":"Richner J.M.; Jagger B.W.; Shan C.; Fontes C.R.; Dowd K.A.; Cao B.; Himansu S.; Caine E.A.; Nunes B.T.D.; Medeiros D.B.A.; Muruato A.E.; Foreman B.M.; Luo H.; Wang T.; Barrett A.D.; Weaver S.C.; Vasconcelos P.F.C.; Rossi S.L.; Ciaramella G.; Mysorekar I.U.; Pierson T.C.; Shi P.Y.; Diamond M.S.; Vaccine mediated protection against zika virus-induced congenital disease. Cell 2017,170(2),273-283.e12","journal-title":"Cell"},{"key":"ref=349","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005608","volume":"11","author":"Boigard H.","year":"2017","unstructured":"Boigard H.; Alimova A.; Martin G.R.; Katz A.; Gottlieb P.; Galarza J.M.; Zika virus-like particle (VLP) based vaccine. PLoS Negl Trop Dis 2017,11(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12250-018-0030-5","volume":"33","author":"Dai S.","year":"2018","unstructured":"Dai S.; Zhang T.; Zhang Y.; Wang H.; Deng F.; Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice. Virol Sin 2018,33(3),213-226","journal-title":"Virol Sin"},{"key":"ref=351","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006210","volume":"12","author":"Salvo M.A.","year":"2018","unstructured":"Salvo M.A.; Kingstad-Bakke B.; Salas-Quinchucua C.; Camacho E.; Osorio J.E.; Zika virus like particles elicit protective antibodies in mice. PLoS Negl Trop Dis 2018,12(2)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijid.2016.11.046","volume":"53","author":"Guirakhoo F.","year":"2016","unstructured":"Guirakhoo F.; Domi A.; McCurley N.; Robinson H.; Development of a Zika vaccine using a novel MVA-VLP platform. Int J Infect Dis 2016,53,16-17","journal-title":"Int J Infect Dis"},{"key":"ref=353","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","volume":"7","author":"Yang M.","year":"2017","unstructured":"Yang M.; Lai H.; Sun H.; Chen Q.; Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci Rep 2017,7(1),7679","journal-title":"Sci Rep"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nm.2105","volume":"16","author":"Akahata W.","year":"2010","unstructured":"Akahata W.; Yang Z.Y.; Andersen H.; Sun S.; Holdaway H.A.; Kong W.P.; Lewis M.G.; Higgs S.; Rossmann M.G.; Rao S.; Nabel G.J.; A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 2010,16(3),334-338","journal-title":"Nat Med"},{"key":"ref=355","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002124","volume":"7","author":"Metz S.W.","year":"2013","unstructured":"Metz S.W.; Gardner J.; Geertsema C.; Le T.T.; Goh L.; Vlak J.M.; Suhrbier A.; Pijlman G.P.; Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis 2013,7(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=356","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108169","volume":"9","author":"Noranate N.","year":"2014","unstructured":"Noranate N.; Takeda N.; Chetanachan P.; Sittisaman P.; A-Nuegoonpipat A.; Anantapreecha S.; Characterization of chikungunya virus-like particles. PLoS One 2014,9(9)","journal-title":"PLoS One"},{"key":"ref=357","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005908","volume":"11","author":"Garrison A.R.","year":"2017","unstructured":"Garrison A.R.; Shoemaker C.J.; Golden J.W.; Fitzpatrick C.J.; Suschak J.J.; Richards M.J.; Badger C.V.; Six C.M.; Martin J.D.; Hannaman D.; Zivcec M.; Bergeron E.; Koehler J.W.; Schmaljohn C.S.; A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLoS Negl Trop Dis 2017,11(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=358","doi-asserted-by":"publisher","first-page":"e02076","DOI":"10.1128\/JVI.02076-16","volume":"91","author":"Hinkula J.","year":"2017","unstructured":"Hinkula J.; Devignot S.; \u00c5kerstr\u00f6m S.; Karlberg H.; Wattrang E.; Bereczky S.; Mousavi-Jazi M.; Risinger C.; Lindegren G.; Vernersson C.; Paweska J.; van Vuren P.J.; Blixt O.; Brun A.; Weber F.; Mirazimi A.; Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and\/or Virus-Like Particles Induces Protection and Survival in Challenged Mice. J Virol 2017,91(10),e02076-e16","journal-title":"J Virol"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/elps.201700217","volume":"38","author":"Gollapudi D.","year":"2017","unstructured":"Gollapudi D.; Wycuff D.L.; Schwartz R.M.; Cooper J.W.; Cheng K.C.; Development of high-throughput and high sensitivity capillary gel electrophoresis platform method for Western, Eastern, and Venezuelan equine encephalitis (WEVEE) virus like particles (VLPs) purity determination and characterization. Electrophoresis 2017,38(20),2610-2621","journal-title":"Electrophoresis"},{"key":"ref=360","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1016\/j.vaccine.2018.09.030","volume":"36","author":"Teng Z.","year":"2018","unstructured":"Teng Z.; Sun S.; Chen H.; Huang J.; Du P.; Dong H.; Xu X.; Mu S.; Zhang Z.; Guo H.; Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine. Vaccine 2018,36(45),6752-6760","journal-title":"Vaccine"},{"key":"ref=361","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4823","volume":"6","author":"Wang G.","year":"2018","unstructured":"Wang G.; Liu Y.; Feng H.; Chen Y.; Yang S.; Wei Q.; Wang J.; Liu D.; Zhang G.; Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus. PeerJ 2018,6","journal-title":"PeerJ"},{"key":"ref=362","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/10837450.2013.784335","volume":"19","author":"Tajdini F.","year":"2014","unstructured":"Tajdini F.; Amini M.A.; Mokarram A.R.; Taghizadeh M.; Azimi S.M.; Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics. Pharm Dev Technol 2014,19(3),333-341","journal-title":"Pharm Dev Technol"},{"key":"ref=363","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/21\/19\/195101","volume":"21","author":"Chen Y.S.","year":"2010","unstructured":"Chen Y.S.; Hung Y.C.; Lin W.H.; Huang G.S.; Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology 2010,21(19)","journal-title":"Nanotechnology"},{"key":"ref=364","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.2147\/IJN.S72318","volume":"9","author":"Pan L.","year":"2014","unstructured":"Pan L.; Zhang Z.; Lv J.; Zhou P.; Hu W.; Fang Y.; Chen H.; Liu X.; Shao J.; Zhao F.; Ding Y.; Lin T.; Chang H.; Zhang J.; Zhang Y.; Wang Y.; Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles. Int J Nanomedicine 2014,9,5603-5618","journal-title":"Int J Nanomedicine"},{"key":"ref=365","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vetmic.2009.05.004","volume":"139","author":"Joyappa D.H.","year":"2009","unstructured":"Joyappa D.H.; Kumar C.A.; Banumathi N.; Reddy G.R.; Suryanarayana V.V.; Calcium phosphate nanoparticle prepared with foot and mouth disease virus P1-3CD gene construct protects mice and guinea pigs against the challenge virus. Vet Microbiol 2009,139(1-2),58-66","journal-title":"Vet Microbiol"},{"key":"ref=366","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.antiviral.2012.09.019","volume":"96","author":"Mohana Subramanian B.","year":"2012","unstructured":"Mohana Subramanian B.; Madhanmohan M.; Sriraman R.; Chandrasekhar Reddy R.V.; Yuvaraj S.; Manikumar K.; Rajalakshmi S.; Nagendrakumar S.B.; Rana S.K.; Srinivasan V.A.; Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency. Antiviral Res 2012,96(3),288-295","journal-title":"Antiviral Res"},{"key":"ref=367","doi-asserted-by":"publisher","first-page":"e00924","DOI":"10.1128\/JVI.00924-17","volume":"91","author":"Puckette M.","year":"2017","unstructured":"Puckette M.; Clark B.A.; Smith J.D.; Turecek T.; Martel E.; Gabbert L.; Pisano M.; Hurtle W.; Pacheco J.M.; Barrera J.; Neilan J.G.; Rasmussen M.; Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development. J Virol 2017,91(22),e00924-e17","journal-title":"J Virol"},{"key":"ref=368","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12896-016-0285-6","volume":"16","author":"Xiao Y.","year":"2016","unstructured":"Xiao Y.; Chen H.Y.; Wang Y.; Yin B.; Lv C.; Mo X.; Yan H.; Xuan Y.; Huang Y.; Pang W.; Li X.; Yuan Y.A.; Tian K.; Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol 2016,16(1),56","journal-title":"BMC Biotechnol"},{"key":"ref=369","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1297-9716-44-48","volume":"44","author":"Guo H.C.","year":"2013","unstructured":"Guo H.C.; Sun S.Q.; Jin Y.; Yang S.L.; Wei Y.Q.; Sun D.H.; Yin S.H.; Ma J.W.; Liu Z.X.; Guo J.H.; Luo J.X.; Yin H.; Liu X.T.; Liu D.X.; Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res (Faisalabad) 2013,44,48","journal-title":"Vet Res (Faisalabad)"},{"key":"ref=370","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1016\/j.vaccine.2010.04.025","volume":"28","author":"Li C.","year":"2010","unstructured":"Li C.; Liu F.; Liang M.; Zhang Q.; Wang X.; Wang T.; Li J.; Li D.; Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL\/6 mice. Vaccine 2010,28(26),4294-4300","journal-title":"Vaccine"},{"key":"ref=371","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.vaccine.2012.01.024","volume":"30","author":"Boudreau E.F.","year":"2012","unstructured":"Boudreau E.F.; Josleyn M.; Ullman D.; Fisher D.; Dalrymple L.; Sellers-Myers K.; Loudon P.; Rusnak J.; Rivard R.; Schmaljohn C.; Hooper J.W.; A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine 2012,30(11),1951-1958","journal-title":"Vaccine"},{"key":"ref=372","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1743-422X-7-279","volume":"7","author":"Branco L.M.","year":"2010","unstructured":"Branco L.M.; Grove J.N.; Geske F.J.; Boisen M.L.; Muncy I.J.; Magliato S.A.; Henderson L.A.; Schoepp R.J.; Cashman K.A.; Hensley L.E.; Garry R.F.; Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virol J 2010,7,279","journal-title":"Virol J"},{"key":"ref=373","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1128\/JVI.01931-09","volume":"84","author":"McGinnes L.W.","year":"2010","unstructured":"McGinnes L.W.; Pantua H.; Laliberte J.P.; Gravel K.A.; Jain S.; Morrison T.G.; Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol 2010,84(9),4513-4523","journal-title":"J Virol"},{"key":"ref=374","first-page":"259","volume":"11","author":"Firouzamandi M.","year":"2016","unstructured":"Firouzamandi M.; Moeini H.; Hosseini S.D.; Bejo M.H.; Omar A.R.; Mehrbod P.; El Zowalaty M.E.; Webster T.J.; Ideris A.; Preparation, characterization, and in ovo vaccination of dextran-spermine nanoparticle DNA vaccine coexpressing the fusion and hemagglutinin genes against Newcastle disease. Int J Nanomedicine 2016,11,259-267","journal-title":"Int J Nanomedicine"},{"key":"ref=375","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/IJN.S54226","volume":"9","author":"Zhao K.","year":"2014","unstructured":"Zhao K.; Zhang Y.; Zhang X.; Li W.; Shi C.; Guo C.; Dai C.; Chen Q.; Jin Z.; Zhao Y.; Cui H.; Wang Y.; Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Int J Nanomedicine 2014,9,389-402","journal-title":"Int J Nanomedicine"},{"key":"ref=376","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1021\/acs.molpharmaceut.7b00826","volume":"15","author":"Zhao K.","year":"2018","unstructured":"Zhao K.; Han J.; Zhang Y.; Wei L.; Yu S.; Wang X.; Jin Z.; Wang Y.; Enhancing mucosal immune response of newcastle disease virus dna vaccine using N-2-hydroxypropyl trimethylammonium chloride chitosan and N,O-carboxymethyl chitosan nanoparticles as delivery carrier. Mol Pharm 2018,15(1),226-237","journal-title":"Mol Pharm"},{"key":"ref=377","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/126794","volume":"2011","author":"Babapoor S.","year":"2011","unstructured":"Babapoor S.; Neef T.; Mittelholzer C.; Girshick T.; Garmendia A.; Shang H.; Khan M.I.; Burkhard P.; A novel vaccine using nanoparticle platform to present immunogenic m2e against avian influenza infection. Influenza Res Treat 2011,2011","journal-title":"Influenza Res Treat"},{"key":"ref=378","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3389\/fimmu.2018.01953","volume":"9","author":"Zacharias Z.R.","year":"2018","unstructured":"Zacharias Z.R.; Ross K.A.; Hornick E.E.; Goodman J.T.; Narasimhan B.; Waldschmidt T.J.; Legge K.L.; Polyanhydride nanovaccine induces robust pulmonary B and T cell immunity and confers protection against homologous and heterologous influenza A virus infections. Front Immunol 2018,9,1953","journal-title":"Front Immunol"},{"key":"ref=379","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jps.2600700406","volume":"70","author":"Kreuter J.","year":"1981","unstructured":"Kreuter J.; Liehl E.; Long-term studies of microencapsulated and adsorbed influenza vaccine nanoparticles. J Pharm Sci 1981,70(4),367-371","journal-title":"J Pharm Sci"},{"key":"ref=380","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1016\/j.vaccine.2009.07.037","volume":"27","author":"Okamoto S.","year":"2009","unstructured":"Okamoto S.; Matsuura M.; Akagi T.; Akashi M.; Tanimoto T.; Ishikawa T.; Takahashi M.; Yamanishi K.; Mori Y.; Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine 2009,27(42),5896-5905","journal-title":"Vaccine"},{"key":"ref=381","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/JVI.01141-13","volume":"88","author":"Herv\u00e9 P.L.","year":"2014","unstructured":"Herv\u00e9 P.L.; Raliou M.; Bourdieu C.; Dubuquoy C.; Petit-Camurdan A.; Bertho N.; El\u00e9ou\u00ebt J.F.; Chevalier C.; Riffault S.; A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2. J Virol 2014,88(1),325-338","journal-title":"J Virol"},{"key":"ref=382","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1038\/s41598-018-25824-8","volume":"8","author":"Singhal C.","year":"2018","unstructured":"Singhal C.; Khanuja M.; Chaudhary N.; Pundir C.S.; Narang J.; Detection of chikungunya virus DNA using two-dimensional MoS nanosheets based disposable biosensor. Sci Rep 2018,8(1),7734","journal-title":"Sci Rep"},{"key":"ref=383","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1039\/C5LC00055F","volume":"15","author":"Yen C.W.","year":"2015","unstructured":"Yen C.W.; de Puig H.; Tam J.O.; G\u00f3mez-M\u00e1rquez J.; Bosch I.; Hamad-Schifferli K.; Gehrke L.; Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip 2015,15(7),1638-1641","journal-title":"Lab Chip"},{"key":"ref=384","first-page":"1","volume":"86","author":"Yuan W.","year":"2016","unstructured":"Yuan W.; Li Y.; Wang J.; Wang J.; Sun J.; A nanoparticle-assisted PCR assay for the detection of encephalomyocarditis virus. Vet Arh 2016,86(1),1-8","journal-title":"Vet Arh"},{"key":"ref=385","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s13337-018-0450-8","volume":"29","author":"Jain B.","year":"2018","unstructured":"Jain B.; Lambe U.; Tewari A.; Kadian S.K.; Prasad M.; Development of a rapid test for detection of foot-and-mouth disease virus specific antibodies using gold nanoparticles. Virusdisease 2018,29(2),192-198","journal-title":"Virusdisease"},{"key":"ref=386","doi-asserted-by":"publisher","first-page":"10192","DOI":"10.1021\/ja036409g","volume":"125","author":"Perez J.M.","year":"2003","unstructured":"Perez J.M.; Simeone F.J.; Saeki Y.; Josephson L.; Weissleder R.; Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J Am Chem Soc 2003,125(34),10192-10193","journal-title":"J Am Chem Soc"},{"key":"ref=387","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1073\/pnas.0406159101","volume":"101","author":"Patolsky F.","year":"2004","unstructured":"Patolsky F.; Zheng G.; Hayden O.; Lakadamyali M.; Zhuang X.; Lieber C.M.; Electrical detection of single viruses. Proc Natl Acad Sci USA 2004,101(39),14017-14022","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=388","first-page":"408","author":"Valdivia-Granda W.","year":"2005 July","unstructured":"Valdivia-Granda W.; Keating C.D.; Kann M.; Beresford R.; Kelley S.O.; Detection of encephalic and hemorrhagic viruses: Integration of micro-and nano-fabrication with computational tools Proceedings of the International Conference on MEMS, NANO and Smart Systems, ICMENS, Banff:2005 July,408-414","journal-title":"Detection of encephalic and hemorrhagic viruses: Integration of micro-and nano-fabrication with computational tools"},{"key":"ref=389","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1039\/c3ob41703d","volume":"11","author":"Mar\u00edn M.J.","year":"2013","unstructured":"Mar\u00edn M.J.; Rashid A.; Rejzek M.; Fairhurst S.A.; Wharton S.A.; Martin S.R.; McCauley J.W.; Wileman T.; Field R.A.; Russell D.A.; Glyconanoparticles for the plasmonic detection and discrimination between human and avian influenza virus. Org Biomol Chem 2013,11(41),7101-7107","journal-title":"Org Biomol Chem"},{"key":"ref=390","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1021\/ac404177c","volume":"86","author":"Zhou C.H.","year":"2014","unstructured":"Zhou C.H.; Zhao J.Y.; Pang D.W.; Zhang Z.L.; Enzyme-induced metallization as a signal amplification strategy for highly sensitive colorimetric detection of avian influenza virus particles. Anal Chem 2014,86(5),2752-2759","journal-title":"Anal Chem"},{"key":"ref=391","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00604-016-2029-7","volume":"184","author":"Chin S.F.","year":"2017","unstructured":"Chin S.F.; Lim L.S.; Pang S.C.; Sum M.S.H.; Perera D.; Carbon nanoparticle modified screen printed carbon electrode as a disposable electrochemical immunosensor strip for the detection of Japanese encephalitis virus. Mikrochim Acta 2017,184,491-497","journal-title":"Mikrochim Acta"},{"key":"ref=392","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.17576\/jsm-2017-4612-21","volume":"46","author":"Lim L.S.","year":"2017","unstructured":"Lim L.S.; Chin S.F.; Pang S.C.; Sum M.S.H.; Perera D.; A novel silver nanoparticles-based sensing probe for the detection of japanese encephalitis virus antigen. Sains Malays 2017,46(12),2447-2454","journal-title":"Sains Malays"},{"key":"ref=393","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2116\/analsci.32.1105","volume":"32","author":"Geng X.","year":"2016","unstructured":"Geng X.; Zhang F.; Gao Q.; Lei Y.; Sensitive impedimetric immunoassay of japanese encephalitis virus based on enzyme biocatalyzed precipitation on a gold nanoparticle-modified screen-printed carbon electrode. Anal Sci 2016,32(10),1105-1109","journal-title":"Anal Sci"},{"key":"ref=394","doi-asserted-by":"publisher","DOI":"10.1088\/2043-6262\/3\/1\/015012","volume":"3","author":"Tran Q.H.","year":"2012","unstructured":"Tran Q.H.; Nguyen T.H.H.; Mai A.T.; Nguyen T.T.; Vu Q.K.; Phan T.N.; Development of electrochemical immunosensors based on different serum antibody immobilization methods for detection of Japanese encephalitis virus. Adv Nat Sci 2012,3","journal-title":"Adv Nat Sci"},{"key":"ref=395","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2004.10.072","volume":"531","author":"Yuan R.","year":"2005","unstructured":"Yuan R.; Zhang L.; Li Q.; Chai Y.; Cao S.; A label-free amperometric immunosenor based on multi-layer assembly of polymerized o-phenylenediamine and gold nanoparticles for determination of Japanese B encephalitis vaccine. Anal Chim Acta 2005,531(1),1-5","journal-title":"Anal Chim Acta"},{"key":"ref=396","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bej.2005.11.014","volume":"28","author":"Zhang L.","year":"2006","unstructured":"Zhang L.; Yuan R.; Chai Y.; Chen S.; Wang N.; Zhu Q.; Layer-by-layer self-assembly of films of nano-Au and Co(bpy)33+ for the determination of Japanese B encephalitis vaccine. Biochem Eng J 2006,28(3),231-236","journal-title":"Biochem Eng J"},{"key":"ref=397","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/19\/40\/405101","volume":"19","author":"Huang S.H.","year":"2008","unstructured":"Huang S.H.; Yang T.C.; Tsai M.H.; Tsai I.S.; Lu H.C.; Chuang P.H.; Wan L.; Lin Y.J.; Lai C.H.; Lin C.W.; Gold nanoparticle-based RT-PCR and real-time quantitative RT-PCR assays for detection of Japanese encephalitis virus. Nanotechnology 2008,19(40)","journal-title":"Nanotechnology"},{"key":"ref=398","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1021\/ac1023843","volume":"83","author":"Zhang H.","year":"2011","unstructured":"Zhang H.; Harpster M.H.; Park H.J.; Johnson P.A.; Wilson W.C.; Surface-enhanced Raman scattering detection of DNA derived from the west nile virus genome using magnetic capture of Raman-active gold nanoparticles. Anal Chem 2011,83(1),254-260","journal-title":"Anal Chem"},{"key":"ref=399","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.bios.2010.08.015","volume":"26","author":"Neng J.","year":"2010","unstructured":"Neng J.; Harpster M.H.; Zhang H.; Mecham J.O.; Wilson W.C.; Johnson P.A.; A versatile SERS-based immunoassay for immunoglobulin detection using antigen-coated gold nanoparticles and malachite green-conjugated protein A\/G. Biosens Bioelectron 2010,26(3),1009-1015","journal-title":"Biosens Bioelectron"},{"key":"ref=400","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.7150\/thno.16093","volume":"6","author":"Zhang L.","year":"2016","unstructured":"Zhang L.; Tong S.; Zhou J.; Bao G.; Accurate quantification of disease markers in human serum using iron oxide nanoparticle-linked immunosorbent Assay. Theranostics 2016,6(9),1353-1361","journal-title":"Theranostics"},{"key":"ref=401","doi-asserted-by":"publisher","first-page":"14036","DOI":"10.1073\/pnas.0406115101","volume":"101","author":"Li H.","year":"2004","unstructured":"Li H.; Rothberg L.; Colorimetric detection of DNA sequences based on electrostatic interactions with unmodified gold nanoparticles. Proc Natl Acad Sci USA 2004,101(39),14036-14039","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=402","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/elan.200804399","volume":"21","author":"Mart\u00ednez-Paredes G.","year":"2009","unstructured":"Mart\u00ednez-Paredes G.; Gonz\u00e1lez-Garc\u00eda M.B.; Costa-Garc\u00eda A.; Genosensor for SARS virus detection based on gold nanostructured screen-printed carbon electrodes. Electroanalysis 2009,21(3-5),379-385","journal-title":"Electroanalysis"},{"key":"ref=403","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2147\/IJN.S31379","volume":"7","author":"Roh C.","year":"2012","unstructured":"Roh C.; A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int J Nanomedicine 2012,7,2173-2179","journal-title":"Int J Nanomedicine"},{"key":"ref=404","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jctb.2721","volume":"86","author":"Roh C.","year":"2011","unstructured":"Roh C.; Jo S.K.; Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip. J Chem Technol Biotechnol 2011,86,1475-1479","journal-title":"J Chem Technol Biotechnol"},{"key":"ref=405","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s12010-017-2592-3","volume":"184","author":"Zaher M.R.","year":"2018","unstructured":"Zaher M.R.; Ahmed H.A.; Hamada K.E.Z.; Tammam R.H.; Colorimetric Detection of Unamplified Rift Valley Fever Virus Genetic Material Using Unmodified Gold Nanoparticles. Appl Biochem Biotechnol 2018,184(3),898-908","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=406","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128215","volume":"10","author":"Shafagati N.","year":"2015","unstructured":"Shafagati N.; Lundberg L.; Baer A.; Patanarut A.; Fite K.; Lepene B.; Kehn-Hall K.; The use of Nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein. PLoS One 2015,10(5)","journal-title":"PLoS One"},{"key":"ref=407","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bios.2012.08.048","volume":"41","author":"Neng J.","year":"2013","unstructured":"Neng J.; Harpster M.H.; Wilson W.C.; Johnson P.A.; Surface-enhanced Raman scattering (SERS) detection of multiple viral antigens using magnetic capture of SERS-active nanoparticles. Biosens Bioelectron 2013,41,316-321","journal-title":"Biosens Bioelectron"},{"key":"ref=408","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/nn901889v","volume":"4","author":"Mitra A.","year":"2010","unstructured":"Mitra A.; Deutsch B.; Ignatovich F.; Dykes C.; Novotny L.; Nano-optofluidic detection of single viruses and nanoparticles. ACS Nano 2010,4(3),1305-1312","journal-title":"ACS Nano"},{"key":"ref=409","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201600739","volume":"6","author":"Balcioglu M.","year":"2017","unstructured":"Balcioglu M.; Rana M.; Hizir M.S.; Robertson N.M.; Haque K.; Yigit M.V.; Rapid Visual Screening and Programmable Subtype Classification of Ebola Virus Biomarkers. Adv Healthc Mater 2017,6(2)","journal-title":"Adv Healthc Mater"},{"key":"ref=410","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1021\/acsnano.7b07021","volume":"12","author":"Brangel P.","year":"2018","unstructured":"Brangel P.; Sobarzo A.; Parolo C.; Miller B.S.; Howes P.D.; Gelkop S.; Lutwama J.J.; Dye J.M.; McKendry R.A.; Lobel L.; Stevens M.M.; A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors. ACS Nano 2018,12(1),63-73","journal-title":"ACS Nano"},{"key":"ref=411","doi-asserted-by":"publisher","first-page":"10974","DOI":"10.1038\/s41598-017-11387-7","volume":"7","author":"Chen Y.","year":"2017","unstructured":"Chen Y.; Ren R.; Pu H.; Guo X.; Chang J.; Zhou G.; Mao S.; Kron M.; Chen J.; Field-Effect Transistor Biosensor for Rapid Detection of Ebola Antigen. Sci Rep 2017,7(1),10974","journal-title":"Sci Rep"},{"key":"ref=412","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1126\/science.297.5586.1536","volume":"297","author":"Cao Y.C.","year":"2002","unstructured":"Cao Y.C.; Jin R.; Mirkin C.A.; Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 2002,297(5586),1536-1540","journal-title":"Science"},{"key":"ref=413","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bios.2016.05.090","volume":"85","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Zhu G.; Qi W.; Li Y.; Song Y.; A versatile quantitation platform based on platinum nanoparticles incorporated volumetric bar-chart chip for highly sensitive assays. Biosens Bioelectron 2016,85,777-784","journal-title":"Biosens Bioelectron"},{"key":"ref=414","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.3390\/s150408605","volume":"15","author":"Baca J.T.","year":"2015","unstructured":"Baca J.T.; Severns V.; Lovato D.; Branch D.W.; Larson R.S.; Rapid detection of Ebola virus with a reagent-free, point-of-care biosensor. Sensors (Basel) 2015,15(4),8605-8614","journal-title":"Sensors (Basel)"},{"key":"ref=415","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/btpr.2279","volume":"32","author":"Joseph N.M.","year":"2016","unstructured":"Joseph N.M.; Ho K.L.; Tey B.T.; Tan C.S.; Shafee N.; Tan W.S.; Production of the virus-like particles of nipah virus matrix protein in Pichia pastoris as diagnostic reagents. Biotechnol Prog 2016,32(4),1038-1045","journal-title":"Biotechnol Prog"},{"key":"ref=416","doi-asserted-by":"publisher","first-page":"12607","DOI":"10.1039\/C8NJ02244E","volume":"42","author":"Bang J.","year":"2018","unstructured":"Bang J.; Park H.; Choi W.I.; Sung D.; Lee J.H.; Lee K.Y.; Kim S.; Sensitive detection of dengue virus NS1 by highly stable affibody-functionalized gold nanoparticles. New J Chem 2018,42(15),12607-12614","journal-title":"New J Chem"},{"key":"ref=417","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.saa.2018.05.047","volume":"202","author":"Vinayagam S.","year":"2018","unstructured":"Vinayagam S.; Rajaiah P.; Mukherjee A.; Natarajan C.; DNA-triangular silver nanoparticles nanoprobe for the detection of dengue virus distinguishing serotype. Spectrochim Acta A Mol Biomol Spectrosc 2018,202,346-351","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=418","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042346","volume":"7","author":"Rai V.","year":"2012","unstructured":"Rai V.; Hapuarachchi H.C.; Ng L.C.; Soh S.H.; Leo Y.S.; Toh C.S.; Ultrasensitive cDNA detection of dengue virus RNA using electrochemical nanoporous membrane-based biosensor. PLoS One 2012,7(8)","journal-title":"PLoS One"},{"key":"ref=419","doi-asserted-by":"publisher","first-page":"23669","DOI":"10.1021\/acs.jpcc.5b07387","volume":"119","author":"Paul A.M.","year":"2015","unstructured":"Paul A.M.; Fan Z.; Sinha S.S.; Shi Y.; Le L.; Bai F.; Ray P.C.; Bio-Conjugated Gold Nanoparticle Based SERS Probe for Ultrasensitive Identification of Mosquito-Borne Viruses Using Raman Fingerprinting. J Phys Chem C Nanomater Interfaces 2015,119(41),23669-23775","journal-title":"J Phys Chem C Nanomater Interfaces"},{"key":"ref=420","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan1589","volume":"9","author":"Bosch I.","year":"2017","unstructured":"Bosch I.; de Puig H.; Hiley M.; Carr\u00e9-Camps M.; Perdomo-Celis F.; Narv\u00e1ez C. F.; Salgado D. M.; Senthoor D.; O'Grady M.; Phillips E.; Durbin A.; Fandos D.; Miyazaki H.; Yen C. W.; G\u00e9lvez-Ram\u00edrez M.; Warke R. V.; Ribeiro L. S.; Teixeira M. M.; Almeida R. P.; Mu\u00f1\u00f3z-Medina J. E.; Ludert J. E.; Nogueira M. L.; Colombo T. E.; Terzian A. C. B.; Bozza P. T.; Calheiros A. S.; Vieira Y. R.; Barbosa-Lima G.; Vizzoni A.; Cerbino-Neto J.; Bozza F. A.; Souza T. M. L.; Trugilho M. R. O.; de Filippis A. M. B.; de Sequeira P. C.; Marques E. T. A.; Magalhaes T.; D\u00edaz F. J.; Restrepo B. N.; Mar\u00edn K.; Mattar S.; Olson D.; Asturias E. J.; Lucera M.; Singla M.; Medigeshi G. R.; de Bosch N.; Tam J.; G\u00f3mez-M\u00e1rquez J.; Clavet C.; Villar L.; Hamad-Schifferli K.; Gehrke L.; Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med 2017,9(409)","journal-title":"Sci Transl Med"},{"key":"ref=421","volume":"2014","author":"Rahman S.A.","year":"2014","unstructured":"Rahman S.A.; Saadun R.; Azmi N.E.; Ariffin N.; Abdullah J.; Yusof N.A.; Sidek H.; Hajian R.; Label-free dengue detection utilizing PNA\/DNA hybridization based on the aggregation process of unmodified gold nanoparticles. J Nanomater 2014,2014","journal-title":"J Nanomater"},{"key":"ref=422","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bios.2017.05.047","volume":"97","author":"Singhal C.","year":"2017","unstructured":"Singhal C.; Pundir C.S.; Narang J.; A genosensor for detection of consensus DNA sequence of Dengue virus using ZnO\/Pt-Pd nanocomposites. Biosens Bioelectron 2017,97,75-82","journal-title":"Biosens Bioelectron"},{"key":"ref=423","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1109\/JSEN.2015.2417911","volume":"15","author":"Rashid J.I.A.","year":"2015","unstructured":"Rashid J.I.A.; Yusof N.A.; Abdullah J.; Hashim U.; Hajian, \u200e R. A Novel Disposable Biosensor Based on SiNWs\/AuNPs Modified-Screen Printed Electrode for Dengue Virus DNA Oligomer Detection. IEEE Sens J 2015,15,4420-4427","journal-title":"IEEE Sens J"},{"key":"ref=424","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics7030047","volume":"7","author":"Garc\u00eda A.A.","year":"2017","unstructured":"Garc\u00eda A.A.; Franco L.S.; Pirez-Gomez M.A.; Pech-Pacheco J.L.; Mendez-Galvan J.F.; Machain-Williams C.; Talavera-Aguilar L.; Espinosa-Carrillo J.H.; Duarte-Villase\u00f1or M.M.; Be-Ortiz C.; Espinosa-de Los Monteros L.E.; Castillo-Pacheco A.; Garcina-Rejon J.E.; Feasibility Study of an Optical Caustic Plasmonic Light Scattering Sensor for Human Serum Anti-Dengue Protein E Antibody Detection. Diagnostics (Basel) 2017,7(3)","journal-title":"Diagnostics (Basel)"},{"key":"ref=425","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.3390\/s130607774","volume":"13","author":"Deng J.","year":"2013","unstructured":"Deng J.; Toh C.S.; Impedimetric DNA biosensor based on a nanoporous alumina membrane for the detection of the specific oligonucleotide sequence of dengue virus. Sensors (Basel) 2013,13(6),7774-7785","journal-title":"Sensors (Basel)"},{"key":"ref=426","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bioelechem.2012.04.006","volume":"88","author":"Nguyen B.T.","year":"2012","unstructured":"Nguyen B.T.; Peh A.E.; Chee C.Y.; Fink K.; Chow V.T.; Ng M.M.; Toh C.S.; Electrochemical impedance spectroscopy characterization of nanoporous alumina dengue virus biosensor. Bioelectrochemistry 2012,88,15-21","journal-title":"Bioelectrochemistry"},{"key":"ref=427","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bios.2012.10.054","volume":"42","author":"Peh A.E.","year":"2013","unstructured":"Peh A.E.; Li S.F.; Dengue virus detection using impedance measured across nanoporous alumina membrane. Biosens Bioelectron 2013,42,391-396","journal-title":"Biosens Bioelectron"},{"key":"ref=428","doi-asserted-by":"publisher","first-page":"27023","DOI":"10.1364\/OE.21.027023","volume":"21","author":"Camara A.R.","year":"2013","unstructured":"Camara A.R.; Gouv\u00eaa P.M.; Dias A.C.; Braga A.M.; Dutra R.F.; de Araujo R.E.; Carvalho I.C.; Dengue immunoassay with an LSPR fiber optic sensor. Opt Express 2013,21(22),27023-27031","journal-title":"Opt Express"},{"key":"ref=429","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1038\/srep03851","volume":"4","author":"Jahanshahi P.","year":"2014","unstructured":"Jahanshahi P.; Zalnezhad E.; Sekaran S.D.; Adikan F.R.; Rapid immunoglobulin M-based dengue diagnostic test using surface plasmon resonance biosensor. Sci Rep 2014,4,3851","journal-title":"Sci Rep"},{"key":"ref=430","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpba.2010.01.001","volume":"52","author":"Kumbhat S.","year":"2010","unstructured":"Kumbhat S.; Sharma K.; Gehlot R.; Solanki A.; Joshi V.; Surface plasmon resonance based immunosensor for serological diagnosis of dengue virus infection. J Pharm Biomed Anal 2010,52(2),255-259","journal-title":"J Pharm Biomed Anal"},{"key":"ref=431","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/20\/21\/215501","volume":"20","author":"Chen S.H.","year":"2009","unstructured":"Chen S.H.; Chuang Y.C.; Lu Y.C.; Lin H.C.; Yang Y.L.; Lin C.S.; A method of layer-by-layer gold nanoparticle hybridization in a quartz crystal microbalance DNA sensing system used to detect dengue virus. Nanotechnology 2009,20(21)","journal-title":"Nanotechnology"},{"key":"ref=432","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.snb.2010.02.021","volume":"146","author":"Zhang G.J.","year":"2010","unstructured":"Zhang G.J.; Zhang L.; Huang M.J.; Luo Z.H.H.; Tay G.K.I.; Lim E.J.A.; Kang T.G.; Chen Y.; Silicon nanowire biosensor for highly sensitive and rapid detection of Dengue virus. Sens Actuators B Chem 2010,146(1),138-144","journal-title":"Sens Actuators B Chem"},{"key":"ref=433","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bios.2016.04.033","volume":"83","author":"Nuzaihan M N, M.","year":"2016","unstructured":"Nuzaihan M N, M.; Hashim U.; Md Arshad M.K.; Kasjoo S.R.; Rahman S.F.; Ruslinda A.R.; Fathil M.F.; Adzhri R.; Shahimin M.; Electrical detection of dengue virus (DENV) DNA oligomer using silicon nanowire biosensor with novel molecular gate control. Biosens Bioelectron 2016,83,106-114","journal-title":"Biosens Bioelectron"},{"key":"ref=434","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1166\/jnn.2013.7220","volume":"13","author":"Huang M.J.","year":"2013","unstructured":"Huang M.J.; Xie H.; Wan Q.; Zhang L.; Ning Y.; Zhang G.J.; Serotype-specific identification of Dengue virus by silicon nanowire array biosensor. J Nanosci Nanotechnol 2013,13(6),3810-3817","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=435","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/ac015675e","volume":"74","author":"Baeumner A.J.","year":"2002","unstructured":"Baeumner A.J.; Schlesinger N.A.; Slutzki N.S.; Romano J.; Lee E.M.; Montagna R.A.; Biosensor for dengue virus detection: sensitive, rapid, and serotype specific. Anal Chem 2002,74(6),1442-1448","journal-title":"Anal Chem"},{"key":"ref=436","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1021\/ac0509206","volume":"77","author":"Zaytseva N.V.","year":"2005","unstructured":"Zaytseva N.V.; Montagna R.A.; Baeumner A.J.; Microfluidic biosensor for the serotype-specific detection of dengue virus RNA. Anal Chem 2005,77(23),7520-7527","journal-title":"Anal Chem"},{"key":"ref=437","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.nano.2016.08.009","volume":"13","author":"Navakul K.","year":"2017","unstructured":"Navakul K.; Warakulwit C.; Yenchitsomanus P.T.; Panya A.; Lieberzeit P.A.; Sangma C.; A novel method for dengue virus detection and antibody screening using a graphene-polymer based electrochemical biosensor. Nanomedicine (Lond) 2017,13(2),549-557","journal-title":"Nanomedicine (Lond)"},{"key":"ref=438","doi-asserted-by":"publisher","DOI":"10.3390\/s18041173","volume":"18","author":"Ariffin E.Y.","year":"2018","unstructured":"Ariffin E.Y.; Tan L.L.; Abd Karim N.H.; Yook Heng L.; Optical DNA Biosensor Based on Square-Planar Ethyl Piperidine Substituted Nickel(II) Salphen Complex for Dengue Virus Detection. Sensors (Basel) 2018,18(4)","journal-title":"Sensors (Basel)"},{"key":"ref=439","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/acssensors.9b00054","volume":"4","author":"Chu H.W.","year":"2019","unstructured":"Chu H.W.; Lai C.S.; Ko J.Y.; Harroun S.G.; Chuang C.I.; Wang R.Y.L.; Unnikrishnan B.; Huang C.C.; Nanoparticle-Based LDI-MS Immunoassay for the Multiple Diagnosis of Viral Infections. ACS Sens 2019,4(6),1543-1551","journal-title":"ACS Sens"},{"key":"ref=440","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.bios.2017.03.046","volume":"94","author":"Adegoke O.","year":"2017","unstructured":"Adegoke O.; Morita M.; Kato T.; Ito M.; Suzuki T.; Park E.Y.; Localized surface plasmon resonance-mediated fluorescence signals in plasmonic nanoparticle-quantum dot hybrids for ultrasensitive Zika virus RNA detection via hairpin hybridization assays. Biosens Bioelectron 2017,94,513-522","journal-title":"Biosens Bioelectron"},{"key":"ref=441","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1021\/acsnano.8b01515","volume":"12","author":"Draz M.S.","year":"2018","unstructured":"Draz M.S.; Lakshminaraasimulu N.K.; Krishnakumar S.; Battalapalli D.; Vasan A.; Kanakasabapathy M.K.; Sreeram A.; Kallakuri S.; Thirumalaraju P.; Li Y.; Hua S.; Yu X.G.; Kuritzkes D.R.; Shafiee H.; Motion-Based Immunological Detection of Zika Virus Using Pt-Nanomotors and a Cellphone. ACS Nano 2018,12(6),5709-5718","journal-title":"ACS Nano"},{"key":"ref=442","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.201700096","volume":"1","author":"Jiang Q.","year":"2017","unstructured":"Jiang Q.; Chandar Y.J.; Cao S.; Kharasch E.D.; Singamaneni S.; Morrissey J.J.; Rapid, point-of-care, paper-based plasmonic biosensor for zika virus diagnosis. Adv Biosys 2017,1","journal-title":"Adv Biosys"},{"key":"ref=443","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/acsinfecdis.7b00110","volume":"3","author":"S\u00e1nchez-Purr\u00e0 M.","year":"2017","unstructured":"S\u00e1nchez-Purr\u00e0 M.; Carr\u00e9-Camps M.; de Puig H.; Bosch I.; Gehrke L.; Hamad-Schifferli K.; Surface-Enhanced Raman Spectroscopy-Based Sandwich Immunoassays for Multiplexed Detection of Zika and Dengue Viral Biomarkers. ACS Infect Dis 2017,3(10),767-776","journal-title":"ACS Infect Dis"},{"key":"ref=444","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.4302","volume":"23","author":"Zhang B.","year":"2017","unstructured":"Zhang B.; Pinsky B.A.; Ananta J.S.; Zhao S.; Arulkumar S.; Wan H.; Sahoo M.K.; Abeynayake J.; Waggoner J.J.; Hopes C.; Tang M.; Dai H.; Diagnosis of Zika virus infection on a nanotechnology platform. Nat Med 2017,23(5),548-550","journal-title":"Nat Med"},{"key":"ref=445","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1038\/s41598-017-07620-y","volume":"7","author":"Shelby T.","year":"2017","unstructured":"Shelby T.; Banerjee T.; Zegar I.; Santra S.; Highly Sensitive, Engineered Magnetic Nanosensors to Investigate the Ambiguous Activity of Zika Virus and Binding Receptors. Sci Rep 2017,7(1),7377","journal-title":"Sci Rep"},{"key":"ref=446","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bios.2017.08.051","volume":"100","author":"Afsahi S.","year":"2018","unstructured":"Afsahi S.; Lerner M.B.; Goldstein J.M.; Lee J.; Tang X.; Bagarozzi D.A.; Pan D.; Locascio L.; Walker A.; Barron F.; Goldsmith B.R.; Novel graphene-based biosensor for early detection of Zika virus infection. Biosens Bioelectron 2018,100,85-88","journal-title":"Biosens Bioelectron"},{"key":"ref=447","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1038\/s41598-018-28035-3","volume":"8","author":"Kaushik A.","year":"2018","unstructured":"Kaushik A.; Yndart A.; Kumar S.; Jayant R.D.; Vashist A.; Brown A.N.; Li C.Z.; Nair M.; A sensitive electrochemical immunosensor for label-free detection of Zika-virus protein. Sci Rep 2018,8(1),9700","journal-title":"Sci Rep"},{"key":"ref=448","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1021\/nl103025u","volume":"10","author":"Yanik A.A.","year":"2010","unstructured":"Yanik A.A.; Huang M.; Kamohara O.; Artar A.; Geisbert T.W.; Connor J.H.; Altug H.; An optofluidic nanoplasmonic biosensor for direct detection of live viruses from biological media. Nano Lett 2010,10(12),4962-4969","journal-title":"Nano Lett"},{"key":"ref=449","doi-asserted-by":"publisher","DOI":"10.1101\/335315","volume":"335315","author":"Ricks K.M.","year":"2018","unstructured":"Ricks K.M.; Shoemaker C.J.; Dupuy L.C.; Flusin O.; Voorhees M.A.; Fulmer A.N.; Six C.M.; Badger C.V.; Schmaljohn C.S.; Schoepp R.J.; Virus-like particles and magnetic microspheres provide a flexible and sustainable multiplexed alphavirus immunodiagnostic platform. bioRxiv 2018,335315","journal-title":"bioRxiv"},{"key":"ref=450","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201707161","volume":"28","author":"Draz M.S.","year":"2018","unstructured":"Draz M.S.; Moazeni M.; Venkataramani M.; Lakshminarayanan H.; Saygili E.; Lakshminaraasimulu N.K.; Kochehbyoki K.M.; Kanakasabapathy M.K.; Shabahang S.; Vasan A.; Bijarchi M.A.; Memic A.; Shafiee H.; Hybrid Paper-Plastic Microchip for Flexible and High-Performance Point-of-Care Diagnostics. Adv Funct Mater 2018,28(26)","journal-title":"Adv Funct Mater"},{"key":"ref=451","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.proche.2012.10.124","volume":"6","author":"Bhatta D.","year":"2012","unstructured":"Bhatta D.; Villalba M.M.; Johnson C.L.; Emmerson G.D.; Ferris N.P.; King D.P.; Lowe C.R.; Rapid detection of foot-and-mouth disease virus with optical microchip sensors. Procedia Chem 2012,6,2-10","journal-title":"Procedia Chem"},{"key":"ref=452","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/v6020640","volume":"6","author":"Zvirbliene A.","year":"2014","unstructured":"Zvirbliene A.; Kucinskaite-Kodze I.; Razanskiene A.; Petraityte-Burneikiene R.; Klempa B.; Ulrich R.G.; Gedvilaite A.; The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody. Viruses 2014,6(2),640-660","journal-title":"Viruses"},{"key":"ref=453","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0039-9140(02)00307-7","volume":"58","author":"Vetcha S.","year":"2002","unstructured":"Vetcha S.; Wilkins E.; Yates T.; Hjelle B.; Rapid and sensitive handheld biosensor for detection of hantavirus antibodies in wild mouse blood samples under field conditions. Talanta 2002,58(3),517-528","journal-title":"Talanta"},{"key":"ref=454","first-page":"247","volume":"39","author":"Liu H.H.","year":"2006","unstructured":"Liu H.H.; Cao X.; Yang Y.; Liu M.G.; Wang Y.F.; Array-based nano-amplification technique was applied in detection of hepatitis E virus. J Biochem Mol Biol 2006,39(3),247-252","journal-title":"J Biochem Mol Biol"},{"key":"ref=455","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1039\/C6LC01263A","volume":"17","author":"Petkovic K.","year":"2016","unstructured":"Petkovic K.; Metcalfe G.; Chen H.; Gao Y.; Best M.; Lester D.; Zhu Y.; Rapid detection of Hendra virus antibodies: an integrated device with nanoparticle assay and chaotic micromixing. Lab Chip 2016,17(1),169-177","journal-title":"Lab Chip"},{"key":"ref=456","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/adhm.201200072","volume":"1","author":"Lisi F.","year":"2012","unstructured":"Lisi F.; Falcaro P.; Buso D.; Hill A.J.; Barr J.A.; Crameri G.; Nguyen T.L.; Wang L.F.; Mulvaney P.; Rapid detection of hendra virus using magnetic particles and quantum dots. Adv Healthc Mater 2012,1(5),631-634","journal-title":"Adv Healthc Mater"},{"key":"ref=457","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jviromet.2015.05.008","volume":"222","author":"Gao Y.","year":"2015","unstructured":"Gao Y.; Pallister J.; Lapierre F.; Crameri G.; Wang L.F.; Zhu Y.; A rapid assay for Hendra virus IgG antibody detection and its titre estimation using magnetic nanoparticles and phycoerythrin. J Virol Methods 2015,222,170-177","journal-title":"J Virol Methods"},{"key":"ref=458","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bios.2017.08.064","volume":"100","author":"Luo B.","year":"2018","unstructured":"Luo B.; Xu Y.; Wu S.; Zhao M.; Jiang P.; Shi S.; Zhang Z.; Wang Y.; Wang L.; Liu Y.; A novel immunosensor based on excessively tilted fiber grating coated with gold nanospheres improves the detection limit of Newcastle disease virus. Biosens Bioelectron 2018,100,169-175","journal-title":"Biosens Bioelectron"},{"key":"ref=459","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1016\/j.bios.2009.03.014","volume":"24","author":"Lin C.H.","year":"2009","unstructured":"Lin C.H.; Hung C.H.; Hsiao C.Y.; Lin H.C.; Ko F.H.; Yang Y.S.; Poly-silicon nanowire field-effect transistor for ultrasensitive and label-free detection of pathogenic avian influenza DNA. Biosens Bioelectron 2009,24(10),3019-3024","journal-title":"Biosens Bioelectron"},{"key":"ref=460","doi-asserted-by":"publisher","first-page":"12534","DOI":"10.1021\/acsami.8b02735","volume":"10","author":"Oh S.","year":"2018","unstructured":"Oh S.; Kim J.; Tran V.T.; Lee D.K.; Ahmed S.R.; Hong J.C.; Lee J.; Park E.Y.; Lee J.; Magnetic Nanozyme-Linked Immunosorbent Assay for Ultrasensitive Influenza A Virus Detection. ACS Appl Mater Interfaces 2018,10(15),12534-12543","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=461","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1039\/C6SC00412A","volume":"7","author":"Sepunaru L.","year":"2016","unstructured":"Sepunaru L.; Plowman B.J.; Sokolov S.V.; Young N.P.; Compton R.G.; Rapid electrochemical detection of single influenza viruses tagged with silver nanoparticles. Chem Sci (Camb) 2016,7(6),3892-3899","journal-title":"Chem Sci (Camb)"},{"key":"ref=462","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1021\/nl301516z","volume":"12","author":"Shen F.","year":"2012","unstructured":"Shen F.; Wang J.; Xu Z.; Wu Y.; Chen Q.; Li X.; Jie X.; Li L.; Yao M.; Guo X.; Zhu T.; Rapid flu diagnosis using silicon nanowire sensor. Nano Lett 2012,12(7),3722-3730","journal-title":"Nano Lett"},{"key":"ref=463","doi-asserted-by":"publisher","first-page":"15707","DOI":"10.1038\/s41598-017-15806-7","volume":"7","author":"Nidzworski D.","year":"2017","unstructured":"Nidzworski D.; Siuzdak K.; Niedzia\u0142kowski P.; Bogdanowicz R.; Sobaszek M.; Ryl J.; Weiher P.; Sawczak M.; Wnuk E.; Goddard W.A.; Jaramillo-Botero A.; Ossowski T.; A rapid-response ultrasensitive biosensor for influenza virus detection using antibody modified boron-doped diamond. Sci Rep 2017,7(1),15707","journal-title":"Sci Rep"},{"key":"ref=464","first-page":"29","volume":"71","author":"Gholami H.","year":"2016","unstructured":"Gholami H.; Emami T.; Golchinfar F.; Madani R.; Gheshlaghchaei S.I.; Development of a Nano-ELISA system for the rapid and sensitive detection of H9N2 avian influenza. Arch Razi Inst 2016,71(1),29-34","journal-title":"Arch Razi Inst"},{"key":"ref=465","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/smll.201303766","volume":"10","author":"Ye W.W.","year":"2014","unstructured":"Ye W.W.; Tsang M.K.; Liu X.; Yang M.; Hao J.; Upconversion luminescence resonance energy transfer (LRET)-based biosensor for rapid and ultrasensitive detection of avian influenza virus H7 subtype. Small 2014,10(12),2390-2397","journal-title":"Small"},{"key":"ref=466","author":"Wiriyachaiporn N.","year":"2013","unstructured":"Wiriyachaiporn N.; Sirikett H.; Dharakul T.; Rapid Influenza a Antigen Detection Using Carbon Nanostrings As Label for Lateral Flow Immunochromatographic Assay Proceedings of the IEEE 13th International Conference on Nanotechnology (IEEE-NANO), Beijing: China, August 5-82013","journal-title":"Rapid Influenza a Antigen Detection Using Carbon Nanostrings As Label for Lateral Flow Immunochromatographic Assay"},{"key":"ref=467","doi-asserted-by":"publisher","DOI":"10.1002\/gch2.201700071","volume":"2","author":"Ahmed S.R.","year":"2018","unstructured":"Ahmed S.R.; Neethirajan S.; Chiral MoS quantum dots: dual-mode detection approaches for avian influenza viruses. Glob Chall 2018,2(4)","journal-title":"Glob Chall"},{"key":"ref=468","doi-asserted-by":"publisher","first-page":"16305","DOI":"10.1038\/s41598-018-34665-4","volume":"8","author":"Arima A.","year":"2018","unstructured":"Arima A.; Tsutsui M.; Harlisa I.H.; Yoshida T.; Tanaka M.; Yokota K.; Tonomura W.; Taniguchi M.; Okochi M.; Washio T.; Kawai T.; Selective detections of single-viruses using solid-state nanopores. Sci Rep 2018,8(1),16305","journal-title":"Sci Rep"},{"key":"ref=469","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bios.2016.12.037","volume":"91","author":"Zheng L.","year":"2017","unstructured":"Zheng L.; Wei J.; Lv X.; Bi Y.; Wu P.; Zhang Z.; Wang P.; Liu R.; Jiang J.; Cong H.; Liang J.; Chen W.; Cao H.; Liu W.; Gao G.F.; Du Y.; Jiang X.; Li X.; Detection and differentiation of influenza viruses with glycan-functionalized gold nanoparticles. Biosens Bioelectron 2017,91,46-52","journal-title":"Biosens Bioelectron"},{"key":"ref=470","doi-asserted-by":"publisher","first-page":"B3084","DOI":"10.1149\/2.0131808jes","volume":"165","author":"Kinnamon D.S.","year":"2018","unstructured":"Kinnamon D.S.; Krishnan S.; Brosler S.; Sun E.; Prasad S.; Screen Printed Graphene Oxide Textile Biosensor for Applications in Inexpensive and Wearable Point-of-Exposure Detection of Influenza for At-Risk Populations. J Electrochem Soc 2018,165(8),B3084-B3090","journal-title":"J Electrochem Soc"},{"key":"ref=471","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.4209\/aaqr.2018.06.0221","volume":"18","author":"Kim H.U.","year":"2018","unstructured":"Kim H.U.; Min J.; Park G.; Shin D.; Sung G.; Kim T.; Lee M.H.; Electrochemical Detection of Airborne Influenza Virus Using Air Sampling System. Aerosol Air Qual Res 2018,18,2721-2727","journal-title":"Aerosol Air Qual Res"},{"key":"ref=472","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/j.bmc.2004.02.042","volume":"12","author":"Critchley P.","year":"2004","unstructured":"Critchley P.; Dimmock N.J.; Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance. Bioorg Med Chem 2004,12(10),2773-2780","journal-title":"Bioorg Med Chem"},{"key":"ref=473","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ab.2005.04.013","volume":"342","author":"Misono T.S.","year":"2005","unstructured":"Misono T.S.; Kumar P.K.R.; Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem 2005,342(2),312-317","journal-title":"Anal Biochem"},{"key":"ref=474","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069121","volume":"8","author":"Gopinath S.C.B.","year":"2013","unstructured":"Gopinath S.C.B.; Awazu K.; Fujimaki M.; Shimizu K.; Shima T.; Observations of immuno-gold conjugates on influenza viruses using waveguide-mode sensors. PLoS One 2013,8(7)","journal-title":"PLoS One"},{"key":"ref=475","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.snb.2016.04.156","volume":"234","author":"Xu L.","year":"2016","unstructured":"Xu L.; Wang R.; Kelso L.C.; Ying Y.; Li Y.; A target-responsive and size-dependent hydrogel aptasensor embedded with QD fluorescent reporters for rapid detection of avian influenza virus H5N1. Sens Actuators B Chem 2016,234,98-108","journal-title":"Sens Actuators B Chem"},{"key":"ref=476","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bios.2016.02.020","volume":"80","author":"Adegoke O.","year":"2016","unstructured":"Adegoke O.; Kato T.; Park E.Y.; An ultrasensitive alloyed near-infrared quinternary quantum dot-molecular beacon nanodiagnostic bioprobe for influenza virus RNA. Biosens Bioelectron 2016,80,483-490","journal-title":"Biosens Bioelectron"},{"key":"ref=477","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.snb.2013.01.035","volume":"181","author":"Sivashanmugan K.","year":"2013","unstructured":"Sivashanmugan K.; Liao J.D.; You J.W.; Wu C.L.; Focused-ion-beam-fabricated Au\/Ag multilayered nanorod array as SERS-active substrate for virus strain detection. Sens Actuators B Chem 2013,181,361-367","journal-title":"Sens Actuators B Chem"},{"key":"ref=478","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.snb.2015.07.068","volume":"228","author":"Han J.H.","year":"2016","unstructured":"Han J.H.; Lee D.; Chew C.H.C.; Kim T.; Pak J.J.; A multi-virus detectable microfluidic electrochemical immunosensor for simultaneous detection of H1N1, H5N1, and H7N9 virus using ZnO nanorods for sensitivity enhancement. Sens Actuators B Chem 2016,228,36-42","journal-title":"Sens Actuators B Chem"},{"key":"ref=479","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bios.2016.03.073","volume":"82","author":"Tseng Y.T.","year":"2016","unstructured":"Tseng Y.T.; Wang C.H.; Chang C.P.; Lee G.B.; Integrated microfluidic system for rapid detection of influenza H1N1 virus using a sandwich-based aptamer assay. Biosens Bioelectron 2016,82,105-111","journal-title":"Biosens Bioelectron"},{"key":"ref=480","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.btre.2015.05.004","volume":"7","author":"Suda Y.","year":"2015","unstructured":"Suda Y.; Nagatomo M.; Yokoyama R.; Ohzono M.; Aoyama K.; Zhang X.; Nakajima K.; Murakami N.; Shinoda T.; Hirota T.; Yanagihara S.; Nishi J.I.; Highly sensitive detection of influenza virus in saliva by real-time PCR method using sugar chain-immobilized gold nanoparticles; application to clinical studies. Biotechnol Rep (Amst) 2015,7,64-71","journal-title":"Biotechnol Rep (Amst)"},{"key":"ref=481","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1128\/AAC.01415-07","volume":"52","author":"Hall P.R.","year":"2008","unstructured":"Hall P.R.; Hjelle B.; Brown D.C.; Ye C.; Bondu-Hawkins V.; Kilpatrick K.A.; Larson R.S.; Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade. Antimicrob Agents Chemother 2008,52(6),2079-2088","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=482","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1021\/nn402062f","volume":"7","author":"Bimbo L.M.","year":"2013","unstructured":"Bimbo L.M.; Denisova O.V.; M\u00e4kil\u00e4 E.; Kaasalainen M.; De Brabander J.K.; Hirvonen J.; Salonen J.; Kakkola L.; Kainov D.; Santos H.A.; Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles. ACS Nano 2013,7(8),6884-6893","journal-title":"ACS Nano"},{"key":"ref=483","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007142","volume":"4","author":"Wiley J.A.","year":"2009","unstructured":"Wiley J.A.; Richert L.E.; Swain S.D.; Harmsen A.; Barnard D.L.; Randall T.D.; Jutila M.; Douglas T.; Broomell C.; Young M.; Harmsen A.; Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One 2009,4(9)","journal-title":"PLoS One"},{"key":"ref=484","doi-asserted-by":"publisher","first-page":"33198","DOI":"10.1074\/jbc.M112.356535","volume":"287","author":"Narayanan A.","year":"2012","unstructured":"Narayanan A.; Kehn-Hall K.; Senina S.; Lundberg L.; Van Duyne R.; Guendel I.; Das R.; Baer A.; Bethel L.; Turell M.; Hartman A.L.; Das B.; Bailey C.; Kashanchi F.; Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem 2012,287(40),33198-33214","journal-title":"J Biol Chem"},{"key":"ref=485","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1099\/vir.0.066084-0","volume":"95","author":"Paul A.M.","year":"2014","unstructured":"Paul A.M.; Shi Y.; Acharya D.; Douglas J.R.; Cooley A.; Anderson J.F.; Huang F.; Bai F.; Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro. J Gen Virol 2014,95(Pt 8),1712-1722","journal-title":"J Gen Virol"},{"key":"ref=486","author":"Williams J.K.","year":"2015","unstructured":"Williams J.K.; Evidence for the Inhibition of Dengue Virus Binding in the Presence of Silver Nanoparticles Masters Thesis, Air Force Institute of Technology: Kadun2015","journal-title":"Evidence for the Inhibition of Dengue Virus Binding in the Presence of Silver Nanoparticles"},{"key":"ref=487","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.antiviral.2017.08.014","volume":"146","author":"Zivcec M.","year":"2017","unstructured":"Zivcec M.; Guerrero L.I.W.; Albari\u00f1o C.G.; Bergeron \u00c9.; Nichol S.T.; Spiropoulou C.F.; Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. Antiviral Res 2017,146,112-120","journal-title":"Antiviral Res"},{"key":"ref=488","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1049\/iet-nbt.2014.0028","volume":"9","author":"Rafiei S.","year":"2015","unstructured":"Rafiei S.; Rezatofighi S.E.; Ardakani M.R.; Madadgar O.; In vitro anti-foot-and-mouth disease virus activity of magnesium oxide nanoparticles. IET Nanobiotechnol 2015,9(5),247-251","journal-title":"IET Nanobiotechnol"},{"key":"ref=489","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2174\/2210681207666170703155244","volume":"8","author":"Rafiei S.","year":"2018","unstructured":"Rafiei S.; Rezatofighi S.E.; Ardakani M.R.; Madadgar O.; Restrictive Influence of Silver Nanoparticles on the Life Cycle of the Foot-and-Mouth Disease Virus. Nanosci Nanotechnol Asia 2018,8(2),248-254","journal-title":"Nanosci Nanotechnol Asia"},{"key":"ref=490","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11671-008-9128-2","volume":"3","author":"Rogers J.V.","year":"2008","unstructured":"Rogers J.V.; Parkinson C.V.; Choi Y.W.; Speshock J.L.; Hussain S.M.; A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation. Nanoscale Res Lett 2008,3(4),129-133","journal-title":"Nanoscale Res Lett"},{"key":"ref=491","author":"Anders C.B.","year":"2012","unstructured":"Anders C.B.; A SERS and SEM-EDX Study of the Antiviral Mechanism of Creighton Silver Nanoparticles against Vaccinia Virus June.2012","journal-title":"A SERS and SEM-EDX Study of the Antiviral Mechanism of Creighton Silver Nanoparticles against Vaccinia Virus"},{"key":"ref=492","author":"Darlington J.W.","unstructured":"Darlington J.W.; Hughes J.; Constantinides P.P.; Fang M.; St. Onge J.H.; Virus-, Bacteria-, and fungi-interacting layered phyllosilicates and methods of use. US Patent 20100272769A1 2005 3August","journal-title":"US Patent 20100272769A1"},{"key":"ref=493","author":"Engel R.","unstructured":"Engel R.; Rizzo J.L.I.; Melkonian-Fincher K.; Antiviral compositions. U.S. Patent 20150196032A1, 2007."},{"key":"ref=494","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2217\/nnm-2018-0089","volume":"13","author":"Tavakoli A.","year":"2018","unstructured":"Tavakoli A.; Ataei-Pirkooh A.; Mm Sadeghi G.; Bokharaei-Salim F.; Sahrapour P.; Kiani S.J.; Moghoofei M.; Farahmand M.; Javanmard D.; Monavari S.H.; Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1. Nanomedicine (Lond) 2018,13(21),2675-2690","journal-title":"Nanomedicine (Lond)"},{"key":"ref=495","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104113","volume":"9","author":"Orlowski P.","year":"2014","unstructured":"Orlowski P.; Tomaszewska E.; Gniadek M.; Baska P.; Nowakowska J.; Sokolowska J.; Nowak Z.; Donten M.; Celichowski G.; Grobelny J.; Krzyzowska M.; Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS One 2014,9(8)","journal-title":"PLoS One"},{"key":"ref=496","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12989-016-0181-1","volume":"14","author":"Sattler C.","year":"2017","unstructured":"Sattler C.; Moritz F.; Chen S.; Steer B.; Kutschke D.; Irmler M.; Beckers J.; Eickelberg O.; Schmitt-Kopplin P.; Adler H.; Stoeger T.; Nanoparticle exposure reactivates latent herpesvirus and restores a signature of acute infection. Part Fibre Toxicol 2017,14(1),2","journal-title":"Part Fibre Toxicol"},{"key":"ref=497","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1556-276X-8-93","volume":"8","author":"Mori Y.","year":"2013","unstructured":"Mori Y.; Ono T.; Miyahira Y.; Nguyen V.Q.; Matsui T.; Ishihara M.; Antiviral activity of silver nanoparticle\/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett 2013,8(1),93","journal-title":"Nanoscale Res Lett"},{"key":"ref=498","first-page":"4303","volume":"8","author":"Gaikwad S.","year":"2013","unstructured":"Gaikwad S.; Ingle A.; Gade A.; Rai M.; Falanga A.; Incoronato N.; Russo L.; Galdiero S.; Galdiero M.; Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomedicine 2013,8,4303-4314","journal-title":"Int J Nanomedicine"},{"key":"ref=499","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/08923973.2013.828743","volume":"35","author":"Manuja A.","year":"2013","unstructured":"Manuja A.; Manuja B.K.; Kaushik J.; Singha H.; Singh R.K.; Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species. Immunopharmacol Immunotoxicol 2013,35(5),535-544","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=500","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.2147\/IJN.S177658","volume":"13","author":"Lin Z.","year":"2018","unstructured":"Lin Z.; Li Y.; Gong G.; Xia Y.; Wang C.; Chen Y.; Hua L.; Zhong J.; Tang Y.; Liu X.; Zhu B.; Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway. Int J Nanomedicine 2018,13,5787-5797","journal-title":"Int J Nanomedicine"},{"key":"ref=501","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1002\/smll.201001349","volume":"6","author":"Papp I.","year":"2010","unstructured":"Papp I.; Sieben C.; Ludwig K.; Roskamp M.; B\u00f6ttcher C.; Schlecht S.; Herrmann A.; Haag R.; Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small 2010,6(24),2900-2906","journal-title":"Small"},{"key":"ref=502","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1021\/bc900215b","volume":"20","author":"Baram-Pinto D.","year":"2009","unstructured":"Baram-Pinto D.; Shukla S.; Perkas N.; Gedanken A.; Sarid R.; Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 2009,20(8),1497-1502","journal-title":"Bioconjug Chem"},{"key":"ref=503","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009706","volume":"6","author":"Thi E.P.","year":"2014","unstructured":"Thi E.P.; Mire C.E.; Ursic-Bedoya R.; Geisbert J.B.; Lee A.C.H.; Agans K.N.; Robbins M.; Deer D.J.; Fenton K.A.; MacLachlan I.; Geisbert T.W.; Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. Sci Transl Med 2014,6(250)","journal-title":"Sci Transl Med"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/180506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:16:39Z","timestamp":1695957399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/180506\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":503,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026620666200325114400","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}